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ABSTRACT 
Several commercial nano-agents are already available for biomedical applications and many 
nanomedicine products are near obtaining final approval for clinical use. Besides biomedical 
applications, nanoparticles (NPs) are used commercially in products such as electronic 
components, scratch-free paint, sports equipment, cosmetics, food colour additives, and 
surface coatings. Hence, our exposure to nanomaterials is significant and increasing, yet there 
is little understanding of the unique toxicological properties of NPs and their long-term 
impact on human health.  
For this reason, in this study we address the issue of cytotoxic and genotoxic effects of 
different metallic nanoparticles two different cell systems. Moreover, this study aim is to 
understand if, modifying the physicochemical characteristics of NPs, it is possible to mitigate 
the toxic effects they are able to induce. Thus a set of 14 different NPs was screened: 4 CuO 
NPs, 3 Au NPs, 4 Ag NPs and 3 SiO2 NPs. Inside every group, the NPs differ for size, shape 
and\or capping. The tests were performed in Raw 264.7 macrophage cells and peripheral 
blood lymphocytes (PBL). Macrophages are one of the principal immune effector cells that 
play essential roles as secretory, phagocytic and antigen-presenting cells in the immune 
system while PBL are present in the circulatory system and are representative of the major 
pathway of NPs distribution in the whole organism.  
The results showed how NPs caused cytotoxicity and genotoxicity with different degrees of 
damage, often in a dose-dependent manner. The NPs set tested induced micronuclei formation 
and DNA damage at different levels. Oxidative stress seemed to be the most probable cause 
of damage, followed by the activation of apoptotic and necrotic pathways. Moreover, CuO 
and Au NPs induced aneuploidogenic events in cells after exposure compared to negative 
control. Nevertheless, it was not possible to ascribe the damage to one single physicochemical 
parameter of the nanoparticles, as all the characteristics seemed to act altogether in cell 
damaging. 
 
Further investigations are required  to better understand  which mechanism(s) is(are) involved 
in the NPs toxicity and if modification in one or more physicochemical parameters could be 
sufficient to make NPs harmless or at least less toxic.  
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INTRODUCTION 
NANOPARTICLES:  DEFINITION AND APPLICATIONS 
In the last two decades, new terms with the prefix `nano' have rushed into the scientific 
vocabulary - nanoparticle, nanostructure, nanotechnology, nanomaterial, nanocluster, 
nanochemistry, nanocolloids, nanoreactor and so on. A series of new journals are devoted 
particularly to this subject, monographs with the corresponding names have appeared, `nano'-
specialised institutes, chairs and laboratories have been founded; and numerous conferences 
are held. In most cases, new names were applied to long known objects or phenomena; 
however, new objects inaccessible for researchers some 20 years ago have also appeared. 
These include fullerenes, quantum dots, nanotubes, nanofilms and nanowires, i.e., the objects 
with at least one nanometer dimension (Gubin et al., 2005). However the definition of 
nanoparticle (NP) is a complex issue. The European community has discussed the topic and 
issued a document: “Scientific Committee on Emerging and Newly Identified Health Risks 
(SCENIHR)” that offers a more complex approach. This document subdivides nanoparticles 
into three categories as explained below. 
Category 1: size > 500 nm  
If the size (e.g. mean, median, etc.) of the material is above 500 nm it is assumed that the size 
distribution at the lower end will most likely be above the designated lower threshold of 100 
nm. This should be confirmed by determination of the size distribution. So, the need for 
further evaluation regarding possible nano-specific properties may be of lower priority and 
thus for the moment classical risk assessment should be performed taking into consideration 
the particulate nature of the material.  
 
Category 2: 500 nm> size >100 nm  
When the size is <500 nm it is more likely that part of the size distribution will be lower than 
100 nm and that a material may be considered a nanomaterial and that therefore a more 
detailed characterization and nano-specific risk assessment will be necessary.  A nano-
specific risk assessment should be undertaken if the characterization demonstrates that 
>0.15% (or any specified percentage) of the number size distribution is <100 nm. If these 
characteristics are not met, the need for further evaluation regarding possible nano-specific 
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properties may be of lower priority and thus for the moment classical risk assessment should 
be performed taking into consideration the particulate nature of the material.  
 
Category 3: 100 nm> size >1 nm  
The material is considered a nanomaterial and nano-specific risk assessment has to be 
performed. A volume specific surface area (VSSA) above the threshold (e.g. >60 m2/cm3) 
may be used as an additional qualifier to indicate a size below 100 nm (SCHENIR).  
Several commercial nano-agents are already available for biomedical applications and many 
nanomedicine products are near obtaining final approval for clinical use (Xu and Sun, 2007; 
Lewin et al., 2000). Besides biomedical applications, NPs are used commercially in products 
such as electronic components, scratch-free paint, sports equipment, cosmetics, food colour 
additives, and surface coatings. Hence, our exposure to nanomaterials is significant and 
increasing, yet there is little understanding of the potential toxicological properties of NPs and 
their long-term impact on human health (Mahmoudi et al., 2011). 
Outcomes from studies on nano-bio interactions in the past decade have greatly influenced 
nanoparticle design. The evolution of nanoparticles destined for biomedical applications has 
occurred in parallel with studies investigating the biological responses to the nanomaterials 
themselves. Material design evolved whenever the effect of size, shape, or surface charge was 
further elucidated. To date, three generations of nanoparticles have been engineered for 
biomedical applications (Figure 1). The first generation consisted of novel nanomaterials 
functionalized with basic surface chemistries to assess biocompatibility and toxicity. The 
second generation produced nanomaterials with optimized surface chemistries that improved 
stability and targeting in biological systems. The third generation shifted the paradigm of 
design from stable nanomaterials to “intelligent” environment-responsive systems that should 
improve targeted compound delivery. The first generation of nanomaterials was synthesized 
to demonstrate the potential applications of novel materials in biomedical research. Before 
this generation, liposome studies in the supra-nanoscale range (100–1,000 nm) established a 
basic research template for evaluation of more modern, smaller materials (1–100 nm). 
Seminal papers from this first generation include those describing the surface modification of 
organic-soluble quantum dots and magnetic nanoparticles to render them water soluble and 
stable enough for biological applications (Nie and Chan, 1998; Gupta and Gupta, 2005). First-
generation nanoparticles were modified with non-stealth surface chemistries and used in 
experiments to assess cell uptake and toxicity (Chithrani et al., 2006; Kirchner et al., 2005). 
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The main focus of these materials was to determine the effects of surface charge (Cho et al., 
2009a; Hauck et al., 2008). However, most of these studies included experiments in serum-
free media or did not account for serum-protein interactions with their nanomaterials, which 
makes the findings difficult to interpret when considering physiological conditions within the 
body. First generation nanomaterials also did not use PEG; thus, most in vivo data show the 
rapid clearance of nanomaterials (De Jong et al., 2008; Cherukuri et al., 2006). These early 
studies were important in highlighting the biocompatibility of these novel materials and 
marked a major step in the transition from chemical synthesis to biological uses. However, the 
poor stability in cell-culture media and rapid clearance from the body shifted research focus to 
increase stability and prolong blood half-life. With nanoparticle synthesis established, 
research shifted to surface chemistry optimization for diagnosing and treating cancer. 
Although nanoparticles were a promising avenue for targeted delivery in many organs and 
tissues, most studies using second-generation nanoparticles focused on tumour delivery as a 
proof of concept. Consequently, second-generation nanomaterials are characterized by two 
important design concepts: stealth and active targeting. The goal of stealth nanoparticles is to 
maximize blood circulation half-life to ensure continuous delivery of nanoparticles into the 
tumour via leaky vasculature. The longer a nanoparticle remains in circulation, the higher 
likelihood it has of entering the tumour. Several studies showed the increased half-life of 
nanomaterials by simply adding PEG to their surface (Owens and Peppas, 2006). The 
chemistry used to attach PEG, overall PEG length, and surface density all affect nanoparticle 
stability (Perrault et al., 2009; Zhang et al., 2009b; Gref et al., 2000). Alternative molecules 
such as lipids and silica were investigated, but PEG remains the most widely used approach 
(Van Schooneveld et al., 2008).  
Researchers recently developed a new generation of nanomaterials that do not rely on passive 
retention of nanoparticles or on endogenous tumour ligands. The third generation of 
nanomaterials has “environment-responsive” properties. These dynamic nanoparticles use 
biological, physical, or chemical cues in their target environment to trigger a change in their 
properties to maximize tumour delivery. Two approaches have been used so far: the first uses 
hallmark cues inside the tumour environment such as low pH, low O2, or matrix-
metalloproteinase enzymatic activity; the second provides an artificial cue such as near-
infrared light inside the target tissue.  
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Figure 1. Evolution of nanoparticle design, highlighting the interplay between evolution of nanomaterial design 
and fundamental nano-bio studies. Abbreviations: Ab, antibody; EPR, enhanced permeation and retention; MPS, 
mononuclear phagocyte system; PEG, poly(ethylene) glycol. From Albanese et al., 2012 
ROUTES OF EXPOSURE 
Due to the increased use of nanomaterials it is inevitable that the human being are exposed to 
NPs, which are able to penetrate into the body. The main routes of entry are through the skin, 
lungs or intestinal tract causing adverse biological effects (Davoren et al., 2007; Li et al., 
2007; Oberdörster et al., 2005; Hoet et al., 2004; Warheit et al., 2004). Other potential routes 
of NPs in the case of biomedical applications include parental administration such as 
intravenous, intradermal and peritoneal exposures into experimental  systems (Stern and 
McNeil, 2008; De Jong et al., 2008). Factors that may influence NPs entry include size, 
charge, surface area and shape. According to Auffan and co-authors nanosized particles have 
an elevated surface/volume ratio of approximately 35- 40% of atoms localized at the surface 
of a 10nm NPs compared with less than 20% for particles larger than 30nm (Auffan et al., 
2008). The toxicity of these materials depends on their persistence or clearance from the 
different organs due to the immune response of the host (Jeffrey et al., 2008). Much research 
has been done on NPs toxicity inside the respiratory tract. These nanomaterials can be inhaled 
naturally in the form of aerosol, powders or artificially by instillation into the respiratory tract 
for toxicity studies (Oberdörster et al., 2005; Hoet et al., 2004; Warheit et al., 2004). The 
respiratory system is the part of the organs that deal with the process of respiration and it is 
responsible for taking in and sending out air from living animals. The lungs are part of the 
respiratory tract responsible for exchange of gases. Inhalation is the most common route of 
exposure to NPs in the workplaces. Once inhaled, these materials are carried by electrostatic 
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force of the air from the upper to the lower respiratory tract (Cross et al., 2007; Oberdörster et 
al., 2005). The particles are usually inhaled in the form of airborne NPs, systemic 
administration of drugs, chemicals and other compounds to the lungs through direct cardiac 
output to the pulmonary arteries (Jeffrey et al., 2008). Immediately the NPs are in the 
pulmonary sites, translocation to blood circulation through the lymphatic pathways can occur 
depending on the nanomaterial size. Also when the NPs are deposited in the alveolar, they are 
usually attacked by the process of phagocytosis. This also led to chemotactic activities which 
trigger the complement system cascade and the inflammatory cell response to the site of NPs. 
According to Oberdörster and colleagues the effect of the inflammatory and the complement 
cascade may take up to 10 days in rat and roughly two years in humans to be cleared. 
Ingestion is another route whereby NPs may enter the body (Oberdörster et al., 2005). Most 
of the toxicity studies pertaining to NPs are focused mainly on respiratory tract (RT) 
exposures with few studies describing the gastrointestinal tract exposures. The gastrointestinal 
tract (GT) exposures usually occur either unintentional from hand to mouth transfer or from 
traditional materials. Furthermore, it could occur during handling of the materials that contain 
the NPs. Other possible gastrointestinal tract exposures may come from particles cleared from 
the respiratory system through the mucociliary escalator (Li et al., 2007; Chen et al., 2006; 
Oberdörster et al., 2005). The GT can be exposed to NPs also by water, food, cosmetics, 
drugs, drug delivery devices. Some studies have investigated the potential intestinal 
absorption and the translocation of NPs and generally found uptake within the GT. More 
critical findings concerning the fate of ingested NPs can be viewed from radioactive metal 
studies, where NPs have been shown to translocate from the gastrointestinal tract to other 
organs (Borm and Kreyling, 2004). Furthermore, NPs administered orally are usually 
absorbed, through the epithelial cells of the Peyer’s patches in the gut-associated lymphoid 
tissue (GALT) and also through the gut enterocytes (Chen et al., 2006; Florence, 2005). Skin 
barrier alterations (such as the wounds, scrapes, or dermatitis) could act as exposures routes to 
NPs into the body and should not be overlooked. Debilitated skin represents a good channel 
for entry of finer and even larger particles (0.5-7μm) as reported by Blundell and 
collaborators (1989). Most of the penetration and distribution of nanomaterials in skin and 
toxicity are minimal and limited to the uppermost stratum corneum layers and areas near hair 
follicles. This usually led to irritation of the inflammation area in experimental animals. This 
is because the stratum corneum is the primary barrier for skin and any type of perturbations of 
the skin (such as an open wound, cut, or alteration to this skin barrier) could expose viable 
skin cells to NPs (Zhang et al., 2008; Cross et al., 2007). Therefore, more toxicological 
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assessment such as abrasion should be conducted to determine if penetration to this barrier 
would allow an enhancement of NPs absorption. This raises the question whether 
nanomaterials could penetrate the dermis, be eventually absorbed systemically, and be 
responsible for an acute/chronic and local/systemic potential health risk. It is already known 
that the skin is nanoporous at the nanoscale, having orifices of hair follicles and glands open 
on skin surface providing alternative entrance routes. There are few literatures reports which 
indicate the eye as route of NPs exposure into animals. Drug delivery is achieved through 
topical application (Aniruddha et al., 2008). However, topical treatment of posterior eye 
infection is not effective due to the rapid precorneal elimination due to solution drainage, long 
diffusional path length, induced lacrimation, and corneal epithelial impermeability (Jarvinen 
et al., 1995). However, NPs have generated considerable interest for drug delivery into the 
eye (Aniruddha et al., 2008). According to Herrero-Vanrell and Refojo (Herrero- Vanrell and 
Refojo, 2001), intravitreally administrations of NPs showed to sustain drug delivery to the 
eye. Recent reports by Farjo and co-authors explained how DNA added on NPs can be 
implored to transfer genes into the mouse retina (Farjo et al., 2006). Jani and colleagues 
reported that albumin encapsulated NPs, when injected into the corneas of uninjured mice, 
were detected in the corneal keratocyte cytoplasm (Jani et al., 2007). The albumin NPs can be 
used to express intraceptors for extended periods that are effective in suppressing injury-
induced corneal neovascularization. The highly efficient transfer of the reporter gene into 
photoreceptor cells could lead to effective treatments for conditions such as retinitis 
pigmentosa. Therefore, by modifying the properties of NPs, they could be made to target 
specific organs. Vertebrates have a pair of ears, which are symmetrically placed on opposite 
sides of the head. Their arrangement and the ability to localize sound sources (waves) can 
passively facilitate the entry of NPs into the inner ear and to the other vital parts of the body 
via blood. However, very few researches had published about the auditory pathway as a 
channel for NPs transport into the ear. This is due the complex natures of the anatomies of the 
ears which contains hollow channels filled with fluid, and have sensory cells that are 
surrounded by hair cells. Some preliminary reports by Dormen and co-authors showed that 
superparamagnetic NPs can be used as drug delivery into the inner ear of guinea pigs and into 
the prilymphatic fluid (Dormen et al., 2005). Another pilot report by Xianxi and colleagues 
(Xianxi et al., 2007) also showed that polylactic/glycolic acid (PLGA) polymer coated with 
iron oxide NPs, applied to the round window membrane of chinchillas, induced by magnetic 
field can enter the inner ear and will be found in multiple locations within the cochlea tissue. 
In biological assessment, intravenous administration of NPs is very important route used in 
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determining toxicological assessment in experimental animals. In the study of De Jong and 
collaborators to determine particle size-dependent organ distribution of gold NPs they 
intravenously injected experimental rat in the tail vein with gold NPs with diameters of 10, 
50, 100 and 250 nm, respectively. Their results gave an oxidative stress in the rat’s liver cells. 
The 10nm gold NPs showed the most widespread presence in the various organ systems 
including brain, heart, kidneys, lungs, testis and thymus (De Jong et al., 2008). Intravenous 
administration of NPs is followed by inflammatory responses, characterized by an increased 
synthesis and secretion of cytokines. Experimental animals absorb NPs from the site of 
injection into the lymphatic system (Thanos et al., 1999). The subcutaneous route involves a 
complex sequence of nanoparticle movement, mostly involving lymph and blood. The 
relevance of intravenous administration of NPs into experimental animals studies to humans 
have been questioned not only in drug delivery but also in vaccination, a modality which 
requires systematic absorption of the encapsulated active drug to achieve a biological 
response (Rocio et al., 1997). The nano-mucus membrane pathway is the lining of most 
endodermal cells that cover the epithelium and are involved in absorption and secretion. They 
line various body cells and cavities that are exposed to the external environment and internal 
organs. It is continuous with the skin, nostrils, lips, ears, the genital and the anus. NPs 
deposited on the various mucus tissues pathway, encounter mucus or epithelial lining fluid. 
This may trigger phagocytosis or contact fibroblasts B cells or endothelial cells resulting into 
the NPs removal (Oberdörster et al., 2005; Brayden, 2001). The mucus membrane is the first 
barrier that confronts NPs that are deposited in the conducting epithelium. Other reports by 
Moghimi and collegues have shown that NPs can be translocated through the mucosal lining 
and epithelial cells of the intestine and associate with the GALT and the blood circulatory 
system (Moghimi et al., 2001). 
It is quite likely that nanoparticles, when reaching the circulation will influence endothelial 
cell membrane function, either due to their direct toxic effects or through some indirect 
mechanisms, e.g., by inducing a cascade of events leading to disruption of tight junctions or 
increasing the membrane permeability of the blood-brain barrier (BBB) (Sharma et al., 2009; 
Lanone and Boczkowski, 2006). The nanoparticles may also stimulate vesicular transport to 
gain access in to the central nervous system (CNS) microenvironment to induce neurotoxicity. 
However, translocation of nanoparticles from blood to brain across the BBB requires 
additional investigation. Another possibility of nanoparticles-induced BBB disruption could 
be due to formation of free radicals and increased oxidative stress. Apart from nanoparticle 
induced disruption of the BBB leading to neurotoxicity, recent advances in nanotechnology 
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resulted in production of polymer nanoparticles that can be used as carriers to transport the 
entrapped or adsorbed drugs across the BBB for better therapeutic potential (Alyautdin et al., 
1997). However, the toxicity of nanocarriers across the BBB is still not well investigated. 
Nanoparticles without surfactant coating are engulfed by mononuclear phagocytes and thus 
unable to reach brain tissue or in cerebrospinal fluid (Calvo et al., 2001). Thus, PEGylated 
polybutylcyanoacrylate nanoparticles are needed to crosses the BBB in a significant amount 
loaded with drugs (Tiwari and Amiji, 2006). It appears that endocytosis within the brain 
endothelial cells play major roles for transfer of coated nanoparticles with drugs into the 
brain. Surface-coated nanoparticles cross the BBB through receptor mediated mechanisms, as 
they could mimic low-density lipoprotein (LDL)  (Sharma et al., 2009; Lanone and 
Boczkowski, 2006; Liu et al., 2006). Nanoparticles combined with the apolipoprotein acts as 
LDL leading to receptor-mediated transcytosis (Kreuter, 2004). For this purpose, 
nanoparticles with similar size to LDL (in the range of 20-25 nm) are most effective in drug 
delivery across the BBB (Zheng et al., 2005; Hagenbuch and Meier, 2003). This is largely 
due to their small size that makes them degradable, and their translocation into endothelial 
cells results in a rapid release of the drug particles into the brain (Lanone and Boczkowski, 
2006). However, polysorbate 80 has some toxic and haemolytic effects that restrict its usage 
in drug delivery to the brain (Sharma et al., 2009; Lanone and Boczkowski, 2006). Apart 
from the physical properties of the nanoparticles, electrostatic charges play important roles in 
transport of nanomaterials across the BBB (Fenart et al., 1999). The cationized nanoparticles 
in vitro have higher brain translocation compared to anionic or neutral nanoparticles (Nagy et 
al., 1983). The cationic charged molecules may occupy anionic areas at the BBB endothelium 
resulting in an increased permeability of cell membranes across the tight junctions (Lockman 
et al., 2004). However, in vivo data regarding brain permeability of cationized nanoparticles 
are still lacking. On the other hand, nanoparticles with either neutral or low concentrations of 
anionic surface coating charges do not disrupt the BBB integrity (Saija et al., 1997). Whereas 
high anionic and/or cationic charged nanoparticles at low concentration (25 µg/kg) in rats 
induce BBB breakdown in less than 60 seconds in a dose dependent manner. This BBB 
disruption is reversible in nature (Koziara et al., 2006). Administration of negatively charged 
nanoparticles in a dose range of 100 μg-200 μg per animal resulted in their accumulation 
within the cellular matrix without apparent neurotoxicity. However, only the free fraction of 
anionic nanoparticles is related to BBB opening (Koziara et al., 2003; Sahagun et al., 1990). 
Thus, both the size and the charge of colloidal drug carriers are important factors in 
nanoparticles-induced drug delivery across the BBB or in brain parenchyma (Kim et al., 
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2006). Since the tight junctions maintaining BBB integrity have a gap of 4-6 nm (Ambruosi et 
al., 2005), these nanoparticles may pass through the endothelial cell membrane rather than via 
inter-endothelial junctions. As nanoparticles are lipid insoluble and endothelial cells lack 
pinocytosis, their penetration into the brain through circumventricular organs lacking a tight 
barrier is also quite likely (Teeguarden et al., 2006). Using this route, nanoparticles may gain 
access to the brain without affecting BBB permeability. However, further studies are needed 
to clarify these issues. 
NANOPARTICLE-CELL INTERACTIONS 
A prototypical nanoparticle is produced by chemical synthesis; then coated with polymers, 
drugs, fluorophores, peptides, proteins, or oligonucleotides, and eventually administered into 
cell cultures or animal models. Nanoparticles were initially considered as benign carriers, but 
multiple studies have demonstrated that their interaction with serum proteins and cell 
membrane receptors is determined by the nanoparticle design, in effect influencing cell 
uptake, gene expression, and toxicity. Nanoparticles can interact with the cell surface 
membrane in multiple scenarios, as shown in Figure 2. 
Interactions between nanoparticle-bound ligands and cellular receptors depend on the 
engineered geometry and the ligand density of a nanomaterial. The nanoparticle acts as a 
scaffold whose design dictates the number of ligands that interact with the receptor target. A 
multivalent effect occurs when multiple ligands on the nanoparticle interact with multiple 
receptors on the cell. The binding strength of complexed ligands is more than the sum of 
individual affinities and is measured as the avidity for the entire complex. A ligand’s binding 
affinity increases proportionally to the size of a nanoparticle owing to a higher protein density 
on the nanoparticle surface. However, when viewed in terms of the downstream signalling via 
the ErbB2 receptor, 40–50-nm gold nanoparticles induced the strongest effect, suggesting that 
other factors beyond binding affinity must be considered. Nevertheless, several studies have 
shown that nanoparticle design can cause differential cell signalling when compared with free 
ligand in solution. For example, the before mentioned 40–50-nm Herceptin-coated gold 
nanoparticles altered cellular apoptosis by influencing the activation of caspase enzymes 
(Jiang et al., 2008b). Similarly, receptor-specific peptides improved their ability to induce 
angiogenesis when conjugated to a nanoparticle surface (Kanaras et al., 2011). Presentation of 
the peptide on a structured scaffold increased angiogenesis, which is dependent on receptor-
mediated signalling. These findings highlight the advantages of having a ligand bound to a 
nanoparticle as opposed to its being free in solution. The nanoparticle surface creates a region 
of highly concentrated ligand, which increases avidity and, potentially, alters cell signalling. 
 
 
15 
 
However, this benefit comes at a cost: nanomaterials can also cause unexpected changes in 
cell signalling. For example, a study showed that 14-nm carbon nanoparticles interact with 
epidermal growth receptors and β1-integrins on rat alveolar II epithelial cells and induce the 
activation of the Akt signalling pathway, causing cell proliferation (Unfried et al., 2008). An 
additional concern with nanoparticle-ligand complexes is the potential denaturation of 
proteins when bound to the engineered surface. The denaturation of a protein can affect 
binding to its receptor, increase non-specific interactions or provoke inflammation. 
Lysozyme, for example, when bound onto gold nanoparticles will denature and interact with 
other lysozyme molecules and produce protein-nanoparticle aggregates (Zhang et al., 2009a). 
Fibrinogen also unfolds when bound to the surface of polyacrylic acid–coated gold 
nanoparticles. The denatured fibrinogen can then bind to the integrin receptor Mac-1 and lead 
to inflammation (Deng et al., 2010). In many cases, nanoparticles enter the cell after binding 
to the receptor target. Once bound, several factors can dictate the behaviour of nanomaterials 
at the nano-bio interface. For instance, a nanoparticle shape directly influences uptake into 
cells: rods show the highest uptake, followed by spheres, cylinders, and cubes. Gratton and 
co-authors determined this ordering using synthesized nanoparticles larger than 100 nm, but 
using sub-100-nm nanoparticles, spheres show an appreciable advantage over rods (Qiu et al., 
2010; Chithrani et al., 2006) probably due to the increase in the aspect ratio of nanorods (the 
aspect ratio of a shape is defined as the length of the major axis divided by the width of the 
minor axis) (Gratton et al., 2008). Although few studies have focused on non-spherical 
nanoparticles thus far, research indicates their interactions with cells may be much more 
complex. For the engineering process, asymmetrical nanoparticles may provide another level 
of control in presenting ligands to the target receptors. Within a given geometric shape, a 
nanomaterial’s dimensions are a strong determinant of total cell uptake. For spherical gold 
nanoparticles, silica nanoparticles, single-walled carbon nanotubes, and quantum dots, a 50-
nm diameter is optimal to maximize the rate of uptake and intracellular concentration in 
certain mammalian cells (Lu et al., 2009; Jin et al., 2009; Chithrani and Chan, 2007). In 
addition to size and shape, the composition of the nanomaterials also affects uptake because 
single-walled carbon nanotubes and gold nanoparticles, each 50 nm in diameter, possess 
endocytosis rates of 10
−3
 min
−1
 and 10
−6
 min
−1
, respectively.  Which ligand is used to coat the 
nanomaterial will also affect downstream biological responses. For example, the uptake and 
cytotoxicity of nanoparticles were significantly altered when the nanoparticles were coated 
with two different proteins targeting the same receptor (Wang et al., 2010). Once bound to 
their receptor, nanoparticles will typically enter the cell via receptor-mediated endocytosis 
 
 
16 
 
(Jiang et al., 2008a; Chithrani et al., 2006; Gao et al., 2005). The binding of the nanoparticle-
ligand conjugate to the receptor produces a localized decrease in the Gibbs free energy, which 
induces the membrane to wrap around the nanoparticle to form a closed-vesicle structure (Gao 
et al., 2005). The vesicle eventually buds off the membrane and fuses with other vesicles to 
form endosomes, which fuse with lysosomes where degradation occurs. The size-dependent 
uptake of nanoparticles is likely related to the membrane-wrapping process. Small 
nanoparticles have less ligand-to-receptor interaction than larger nanoparticles do. A 5-nm 
nanoparticle coated with 50-kDa proteins may interact with only one or two cell receptors. By 
contrast, a 100-nm nanoparticle has many more ligand-receptor interactions per particle. 
Several small ligand-coated nanoparticles must bind to receptors in close proximity to one 
another to produce enough free energy to drive membrane wrapping. Larger nanoparticles can 
act as a cross-linking agent to cluster receptors and induce uptake. Thermodynamically, a 40–
50-nm nanoparticle is capable of recruiting and binding enough receptors to successfully 
produce membrane wrapping. Above 50 nm, nanoparticles bind such a large number of 
receptors that uptake is limited by the redistribution of receptors on the cell membrane via 
diffusion to compensate for local depletion. Nanoparticles larger than 50 nm bind with high 
affinity to a great number of receptors and may limit the binding of additional nanoparticles. 
Mathematical model of this phenomenon has demonstrated that optimal endocytosis occurs 
when there is no ligand shortage on the nanoparticle and no localized receptor shortage on the 
cell surface (Yuan et al., 2010). This situation occurs in nanoparticles from 30 to 50 nm in 
diameter where ligand density is optimal. Because each cell type possesses a unique 
phenotype, optimal nanoparticle uptake size may depend on the cell being assayed. Each cell 
type can express varying levels of target receptor and can utilize different internalization 
pathways.  The behaviour of nanoparticles in endolysosomal vesicles remains a mystery. 
Some evidence suggests that the nanoparticle ligands are cleaved by the protease Cathepsin-L 
inside endolysosomal vesicles (See et al., 2009). In macrophages, quantum dots seem to 
remain in intracellular vesicles for an extended period of time as degradative enzymes slowly 
decompose the core structure (Fischer et al., 2010). The localization of nanoparticles in the 
intracellular space may be directed using peptides such as the mitochondrial localization 
sequence. If a nanoparticle is engineered to escape the endolysosomal system, it can enter the 
cytosol, where it is free to interact with a wide number of organelles and can affect cell 
behaviour. Once in the cytosol, nanoparticles can elicit biological responses by disrupting 
mitochondrial function, eliciting production of reactive oxygen species and activation of the 
oxidative stress-mediated signalling cascade (AshaRani et al., 2009). The production of 
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reactive oxygen species can have detrimental effects on the mitochondrial genome, induce 
oxidative DNA damage, and promote micronuclei formation (Berneburg et al., 2006). 
Furthermore, certain types of nanoparticles can induce nuclear DNA damage, leading to gene 
mutations, cell-cycle arrest, cell death, or carcinogenesis (Onuma et al., 2009). Once in the 
cytoplasm, nanoparticles will persist unless they are sorted back into the endolysosomal 
system where they can be exocytosed. Nanoparticles that persist in the cytosol during mitosis 
will be distributed within the daughter cells (Rees et al., 2011). However, the effect of the 
nanoparticles on subsequent cell generations remains unclear. To date, there is no consensus 
on the toxicity and properties of nanoparticles inside the cytoplasm. When compared with 
other sizes, 30-nm amorphous TiO2 and 15-nm silver nanoparticles induce the highest 
generation of reactive oxygen species (Carlson et al., 2008; Jiang et al., 2008a).However, in 
other studies, the effect of nanoparticle size does not appear to be significant. For instance, the 
uptake of silver nanoparticles and quantum dots into macrophages induces the expression of 
inflammatory mediators such as TNF-α, MIP-2, and IL-1β independent of size (Fischer et al., 
2010; Carlson et al., 2008). In addition to a nanomaterial’s size, shape, and ligand density, 
surface charge is also important in dictating cellular fate. Compared with nanoparticles with 
neutral or negative charge, positively charged nanoparticles are taken up at a faster rate 
(Thorek and Tsourkas, 2008; Slowing et al., 2006). It has been suggested that the cell 
membrane possesses a slight negative charge and cell uptake is driven by electrostatic 
attractions (Wang et al., 2010; Jin et al., 2009). A recent study demonstrated that this 
electrostatic attraction between membrane and positively charged nanoparticles favours 
adhesion onto the cell’s surface, leading to uptake. For small nanoparticles (2 nm), a positive 
charge can perturb the cell membrane potential, causing Ca
2+
 influx into cells and the 
inhibition of cell proliferation (Mukherjee et al., 2010). For larger nanoparticles (4– 20 nm), 
surface charge induces the reconstruction of lipid bilayers (Wang et al., 2008). Binding of 
negatively charged nanoparticles to a lipid bilayer causes local gelation, whereas binding of 
positively charged nanoparticles induces fluidity. Several studies have confirmed the pivotal 
role surface charge plays in downstream biological responses to nanoparticles. It is important 
to remember that, in the presence of serum or other biological environments, the nanomaterial 
surface charge is quickly covered by a corona made up of multiple proteins. Because the 
surface charge affects corona composition, studies comparing positively and negatively 
charged nanoparticles may be describing the effects of corona composition. This phenomenon 
was observed when negatively charged citrate-capped gold nanoparticles were incubated with 
cells in culture (Chithrani and Chan, 2007; Chithrani et al., 2006). Another example using 
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negatively charged DNA-coated nanoparticles shows their interaction with serum proteins is 
responsible for cell uptake (Giljohann et al., 2007). 
 
 
Figure 2. Nanoparticle-cell interactions. (a) List of factors that can influence nanoparticle-cell interactions at the nano-bio 
interface. (b) Ligand-coated nanoparticles interacting with cells.  1)The ligand-coated nanoparticles bind to receptors on the 
membrane and induce a signalling cascade without entering the cell. 2) The ligand-coated nanoparticles can also be 
internalized and exocytosed by the cell, without ever leaving the vesicle. They bind to the membrane receptor, enter the cells, 
and then exit from the cell.3) Internalized nanoparticles can escape the vesicle and interact with various organelles. They bind 
on membrane receptors, enter the cell, and target subcellular structures. 4) Nanoparticles can interact non-specifically with 
the cell surface membrane. They are subsequently internalized. (Albanese et al., 2012) 
 
As already described, when nanoparticles come into contact with a biological fluid their 
surface will be covered with a “corona” of biological macromolecules. The composition of 
the corona depends on the nanoparticle size and surface characteristics,(Lundqvist et al., 
2008; Lynch and Dawson, 2008) which determine protein binding specificities and affinities. 
Thus, some particles will have a stable hard core of biological macromolecules (named hard 
corona) that interact strongly with the surface as well as a more loosely bound outer layer of 
biological macromolecules that associate less strongly both to the particle surface and to the 
strongly associated biological macromolecules. Some particles will only have a “weak” 
corona, meaning that most of the biological macromolecules will have a weak association to 
the surface, for example, pegylated particles. Assuming a sufficiently long residence time, the 
biological macromolecules that surround a nanoparticle will determine its biological fate, 
because cells “see” and interact with this corona of biomolecules. The majority of the 
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identified biological macromolecules surrounding nanoparticles are proteins, though recently 
the presence of some lipids has been reported (Hellstrand et al., 2009). Cederval and co-
authors have reported detailed pictures for the “hard” corona formed around nanoparticles of 
different materials, including copolymer and polystyrene nanoparticles, of different sizes and 
with different surface properties (Lundqvist et al., 2008; Cedervall et al., 2007a; Cedervall et 
al., 2007b). The importance of the protein corona for determining any possible toxicity from 
different nanoparticles has been reported (Clift et al., 2010; Maiorano et al., 2010) as well as 
the interactions between the proteins that build up the corona and the copolymer particles 
(Dell’Orco et al., 2010; Cedervall et al., 2007a). These data were used to generate a 
theoretical model for the formation of the corona around the copolymer particles over time. 
The model shows that immediately after being introduced into the blood the particle will be 
surrounded by serum albumin, but with time the serum albumin will be replaced with less 
abundant proteins that have a higher association rate constant and lower dissociation rate 
constant (Dell’Orco et al., 2010). Casals and collaborators have also shown the transition 
from a loosely attached protein corona from media containing 10% of foetal bovine serum 
around gold nanoparticles that over time, evolves toward an irreversible attached protein 
corona (Casals et al., 2010). All these data suggested that the nanoparticle biomolecule corona 
is not static, but rather evolves as the particles are trafficked with cells (Lynch et al., 2006).  
As previously described, NPs can exert toxicity once they enter into the cell environmental. 
Several studies were focussed particularly on genotoxicity: one of the most important effects 
the NPs determine is the DNA damage, since the cancer development is strictly linked to the 
increase of genomic instability.  Although nuclear pores have a diameter less than 8 nm, some 
studies demonstrated the ability of some NPs to penetrate inside the nucleus. (Chen et al., 
2006,  AshaRani et al., 2009). Probably, the contact with the DNA occur during the mitosis, 
when a direct interaction with the DNA is possible due to the nuclear membrane breakage: 
NPs can interfere with mitotic spindle originating aneuploidy (Gonzalez et al., 2008). Another 
possible mechanism is represented by the NPs capacity  of increasing the permeability of the 
lysosomal membrane, which cause the release of lysosomal enzymes: these enzymes can enter 
inside the nucleus, causing DNA breakage (Banasik et al., 2005). A key mechanism which 
can explain NPs ability in inducing DNA damage is the increase of oxidative stress (Nel et 
al.,2006; Schins, 2002). The oxidative pressure determined by the increase of reactive oxygen 
species (ROS), such as  H2O2 and OH∙, is caused by the NPs capacity of generating oxidants 
and causing DNA damage, simulating cellular targets to product oxidative and genotoxic 
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compounds, such as those which are involved in the electron chain in the mitochondria or 
those which induce P450 enzyme, and causing inflammation. 
There is a direct relationship between the surface area, ROS-generating capability, and 
proinflammatory effects of nanoparticles in the lung. From a mechanistic perspective, ROS 
generation and oxidative stress is the best developed paradigm to explain the toxic effects of 
inhaled nanoparticles (Nel, 2005; Shvedova et al., 2005; Oberdoster et al., 2005; Donaldson 
et al., 2004; Bell, 2003; Donaldson and Tran, 2002; Donalsdon et al., 2001). Under normal 
coupling conditions in the mitochondrion, ROS are generated at low frequency and are easily 
neutralized by antioxidant defences such as glutathione (GSH) and antioxidant enzymes. 
However, under conditions of excess ROS production, such as may occur in the lung and 
possibly the circulatory system during ambient or occupational nanoparticle exposures (Nel, 
2005), the natural antioxidant defences may be overwhelmed. Oxidative stress refers to a state 
in which GSH is depleted while oxidized glutathione (GSSG) accumulates (Halliwell and 
Gutteridge, 1999). Cells respond to this drop in the GSH/GSSG ratio by mounting protective 
or injurious responses (Bell, 2003; Xiao et al., 2003). The oxidative stress resulting from real-
life ambient and occupational particle exposures, as well as experimental challenge with 
ambient particulate matter (PM), quartz, carbon black or TiO2 nanoparticles, results in airway 
inflammation and interstitial fibrosis (Nel, 2005; Shvedova et al., 2005; Oberdoster et al., 
2005; Donaldson et al., 2004; Bell, 2003; Donaldson and Tran, 2002; Donalsdon et al., 2001). 
Mechanistic studies that use discovery tools such as proteomics and genomics have proven 
useful for substantiating mechanistic hypotheses explaining the biology of oxidative stress, 
and developing biomarkers. According to the hierarchical oxidative stress hypothesis, the 
lowest level of oxidative stress is associated with the induction of antioxidant and 
detoxification enzymes (Xiao et al., 2003). The genes that encode the phase II enzymes are 
under the control of the transcription factor Nrf-2. Nrf-2 activates the promoters of phase II 
genes via an antioxidant response element (ARE) (Xiao et al., 2003). Defects or aberrancy of 
this protective response pathway may determine disease susceptibility during ambient particle 
exposure. At higher levels of oxidative stress, this protective response is overtaken by 
inflammation and cytotoxicity (Fig. 3). Inflammation is initiated through the activation of pro-
inflammatory signalling cascades [e.g., mitogen-activated protein kinase (MAPK) and nuclear 
factor kB (NF-kB) cascades], whereas programmed cell death could result from mitochondrial 
perturbation and the release of pro-apoptotic factors (Fig. 3). It is noteworthy that several 
different types of nanoparticles, including ambient ultrafines, target mitochondria directly 
(Oberdoster et al., 2005; Xiao et al., 2003). A number of responses at each level of oxidative 
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stress have now been successfully incorporated as screening assays for toxicological effects of 
ambient PM in vivo, for example, increased expression of antioxidant enzymes and cytokines 
in the lungs of exposed animals. Moreover, knockout or genetic polymorphisms of genes that 
encode for phase II enzymes establish a susceptibility mechanism that may determine why 
only some individuals develop PM-induced injury (Gilliland et al., 2004). Characterization of 
particle size and physical characteristics, together with in vitro assays for ROS and oxidative 
stress (phase II responses, inflammation, and mitochondrion mediated apoptosis) plus in vivo 
markers of oxidative stress (e.g., lipid peroxidation and signature cytokines), is an example of 
a predictive paradigm for toxicity screening. Similar paradigms can be developed for 
engineered NP. These assays can be supplemented with nanosensor systems that are designed 
to interrogate the abilities of NP to generate ROS. In addition to the paradigm of oxidative 
stress and inflammation, it is important to consider that some of the NP interactions may also 
results in other forms of injury, such as protein denaturation, membrane damage, DNA 
damage, immune reactivity, and the formation of foreign body granulomas. It is also possible 
that new NP properties may emerge that can lead to novel mechanisms of toxicity.  
 
 
Figure 3. The hierarchical oxidative stress model. At a lower amount of oxidative stress (tier 1), phase II 
antioxidant enzymes are induced via transcriptional activation of the antioxidant response element by Nrf-2 to 
restore cellular redox homeostasis. At an intermediate amount of oxidative stress (tier 2), activation of the 
MAPK and NF-kB cascades induces pro-inflammatory responses. At a high amount of oxidative stress (tier 3), 
perturbation of the mitochondrial PT pore and disruption of electron transfer results in cellular apoptosis or 
necrosis. N/A means not applicable. From Nel et al., 2006 
 
NPs can also induce peroxidation of lipids. Lipid peroxidation products are among the most 
common types of oxygenated molecules implicated in oxidative stress responses. Overall, 
lipid peroxidation reactions are sub-categorized into two types: enzymatic and non-enzymatic. 
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The latter proceed as typical “free radical” reactions whereby the oxidation rates are defined 
mainly by the number of double bonds in their polyunsaturated fatty acid residues. 
Consequently, this random process should affect all different (phospho)lipid classes with six, 
five and four double bonds.  
 
EFFECT OF NPs PHYSICOCHEMICAL PROPERTIES ON TOXICITY 
Nanomaterial structures are more likely to be toxic than the same materials of conventional 
sized samples. The very small size distribution and large surface area of nanoparticles 
available to undergo reactions may play a significant role in nanotoxicity, but other physic-
chemical parameters must be take into account in the evaluation of NPs toxicity. Dissolution, 
chemical composition, size, shape, agglomeration state, crystal structure, specific surface 
area, surface energy, surface charge, surface morphology and surface coating influence the 
biological interaction of NPs, and hence it is important to evaluate these properties in 
determining toxic potential of nanomaterials. Particle size and surface area are crucial 
material characteristics from a toxicological point of view, as interactions between 
nanomaterials and biological organisms typically take place at the surface of the NPs. As the 
particles size decreases, the surface area exponentially increases and a greater proportion of 
the particles atoms or molecules will be displayed on the surface rather than within the bulk of 
the material. Thus, the nanomaterial surface becomes more reactive toward itself or 
surrounding biological components with decreasing size, and the potential catalytic surface 
for chemical reactions increases (Sharifi et al., 2012). Since it is known that endocytic mode, 
cellular uptake and efficiency of particle processing in the endocytic pathway are dependent 
on size of material (Aillon et al., 2009; Nel et al., 2006; Lanone and Boczkowski, 2006; 
Rejman et al., 2004); size plays a key role in physiological response, distribution, and 
elimination of materials. A series of studies in rodents using a variety of different NPs showed 
that surface area is a critical factor in provoking lung and other epithelial-induced 
inflammatory responses. When equal mass doses of fine or ultrafine particles of the same 
composition were inhaled by rats, the latter caused greater pulmonary inflammation. 
However, there was not any difference between them when the particle dose was normalized 
to the equivalent total particle surface area  (Holgate, 2010). The lung is an effective barrier 
against the uptake and distribution of NPs. In order to show toxic effects, NPs first need to 
traverse the epithelial barrier. NPs usually enter cells through energy-dependent endocytosis, 
non-phagocytic mechanisms or through receptor mediated endocytosis. Although it seems 
that size can be useful for assessing the toxic potential of some NPs, there is a consensus that 
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NP surface area or size is not the only physicochemical property that determines toxicity. 
Usually there is no precision in size determination as particle aggregation and agglomeration 
and the physicochemical properties of dispersion medium can also influence the ultimate 
particle size and related toxicity (Wiebert et al., 2006). The harmfulness of NPs may arise 
from their size-related ability to readily enter biological systems and modify the structure of 
proteins through formation of new NP–protein complexes or enhanced protein degradation 
(Lovric et al., 2005). Several studies indicated that small size, and consequently a large 
surface area, enhance the generation of ROS. The electron donor or acceptor sites on the NPs 
react with molecular oxygen, resulting in formation of superoxide anions or hydrogen 
peroxide, which subsequently oxidizes other molecules (Aggarwal et al., 2009; Mailander and 
Landfester, 2009). This phenomenon plays a role in the ability of NPs to induce another tissue 
injury. Recently Jiang and co-authors showed that binding and activation of membrane 
receptors and subsequent protein expression strongly depend on NP size (Jiang et al., 2008b). 
Apart from size dependent toxicity of NPs toward respiratory organs, oral toxicity of NPs has 
been shown to have significant correlation with size in spite of the fact that the 
gastrointestinal tract offers physical, chemical, and cell-based barriers against the uptake of 
NPs. Nanoparticle size has an important effect on the rate and route of clearance from the 
body, especially in parenteral dosage forms. For example, although the inert nature of bulk 
gold suggests it is a safe substrate for nanomaterials, NPs smaller than 50 nm administrated 
by intravenous injection are potentially toxic and disperse quickly to nearly all tissues, 
accumulating in blood, heart, lungs, liver, spleen, kidney, thymus, brain and reproductive 
organs. Larger particles (100–200 nm) were found in the RES tissues but not as widely 
dispersed into other tissues as were the smaller particles (De Jong and Borm, 2008). This 
implies that although NP surface area is important in toxicity, other factors such as chemistry 
play a role. Particle shapes and aspect ratios are two additional key factors that determine the 
toxicity of NPs. Nanomaterials can have very different shapes including fibres, spheres, tubes, 
rings, and planes. It had been suggested that endocytosis of spherical NPs is easier and faster 
compared to rod-shaped or fibre-like NPs (Verma and Stellacci, 2010). Rod-shaped or needle-
like NPs can have a larger contact area with the cell membrane receptors than spherical NPs 
when the longitudinal axis of the rods interacts with the receptors. Hence, the ends with high 
curvature at the half-cup stage of endocytosis are very likely to cause a higher membrane 
surface energy, resulting in a large distorting force that exceeds the maximum force provided 
by the actin polymerization. This effect stalls the growing ends of the phagocytic cup and 
results in impaired phagocytosis and the macrophage spreading onto the material rather than 
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internalizing it (Champion and Mitragotri, 2006). Because of this, disc-like, cylindrical and 
hemispherical particles substantially outperform spherical particles in terms of evading uptake 
by phagocytic cells; consequently these non-spherical particles are more disposed to flow 
through capillaries and adhere to blood vessel walls, thus causing other biological 
consequences  (Lu et al., 2010; Doshi and Mitragotri, 2010). Long fibres such as long carbon 
nanofibers block stomata pores and meanwhile damage mesothelial and endothelial cell. 
Accumulation of pleural macrophages attempting to phagocytose these retained fibres results 
in frustrated phagocytosis. The macrophages release cytokines and oxidants that cause further 
inflammation, fibrosis and genotoxicity to the bystander mesothelial cells in these areas of 
congestion around the stomatal entrances (Donaldson et al., 2010). A shape dependent 
toxicity has been observed with silica and TiO2 allotropes as well (Murphy et al., 2011). 
Surface charge also plays a role in toxicity, as it influences the adsorption of ions and 
biomolecules that may change organism or cellular responses toward particles. In addition, 
surface charge is a major determinant of colloidal behaviour, which influences the organism 
response by changing the shape and size of NPs through aggregate or agglomerate formation. 
In general, it is believed that cationic surfaces are more toxic than anionic surfaces, whereas 
neutral surfaces are the most biocompatible  (Hoshino et al., 2004). This may be due to the 
affinity of cationic particles to the negative phospholipid head groups or protein domains on 
cell membranes. In addition surface charge influences plasma protein binding, which in turn 
affects the in vivo organ distribution and clearance of NPs from the circulation (Goodman et 
al., 2004). Nanoparticle surface charge has been observed to alter blood–brain barrier 
integrity and permeability. Particle surface charge can also impact transdermal permeation of 
charged NPs. It was found that after dermal administration, negatively charged NPs of about 
50 and 500 nm permeated the skin, while positively charged and neutral particles of all sizes 
did not. NPs of 50 nm permeate the skin due to the small size and large specific surface area, 
whereas 500 nm particles permeate the skin because the high number and density of charged 
groups leads to a high charge concentration that overcomes the skin barrier  (Lockman et al., 
2004).  
Although it has been suggested that size or surface area may be more important than chemical 
composition in conferring NPs toxicity, particle chemistry is more relevant in relation to cell 
molecular chemistry and oxidative stress. It appears that the toxicity of NPs is not a generic 
response to nanoscopic dimensions; rather, it seems that multiple particular characteristics 
affect toxicity, including but not limited to chemical composition, surface charge, size, and 
shape. The adverse effects of NPs maybe mitigated or eliminated by incorporation of surface 
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coatings. Proper surface coatings can stabilize particles and avoid agglomeration. Coating is 
also an effective means of preventing the dissolution and release of toxic ions (Kirchner et al., 
2005). Furthermore the steric hindrance of coatings can retard the cellular uptake and 
accumulation of NPs, or coatings can facilitate NP endocytosis. Surface coatings can modify 
the surface charge or surface composition, which can impact intracellular distribution and the 
production of ROSs that cause further toxicity. Many coatings are environmentally labile or 
degradable and may shed or degrade after exposure to biological media, thus rendering an 
initially nontoxic material a hazardous one. Severe inflammatory and immunological 
responses can occur dependent on the density and type of surface coating. In some NPs such 
as QDs, a coating is unavoidable as the metallic core is hydrophobic, and the core itself is 
toxic as it is composed of heavy metals such as cadmium. Thus, a secondary coating is needed 
to increase the QD core’s durability, prevent ion leaching, and increase water dispersibility 
(Zhao et al., 2010; Su et al., 2009; Guo et al., 2007; Derfus et al., 2004). Coatings may not be 
stable under oxidative or photolytic conditions thus exposing the metalloid core, which may 
be toxic or pave the way for unforeseen reactions of the QD inside the body (Su et al., 2009). 
The charge of surface coatings may affect the toxicity of QD NPs (Hardman, 2006; Mancini 
et al., 2008). Polyethylene glycol (PEG) is a FDA (Food and Drug Administration) approved 
biocompatible polymer that generally does not induce any toxicity, so PEG has been used 
extensively for coating QDs. Although PEGylation may reduce the potential of harmful 
biological interactions, Cho and co-authors found that 13 nm sized Au NPs coated with PEG 
5000 induce acute inflammation and apoptosis in the mouse liver. A relatively high 
concentration of PEG on the NPs surface alone does not lead to a lower NP uptake, but rather 
the spatial configurational freedom of PEG chains on the particle surface plays a determinant 
role (Cho et al., 2009b). Altogether, most studies have indicated that surface coatings can 
alter the pharmacokinetics, distribution, accumulation, and toxicity of NPs (Hu et al., 2007). 
 
BIOLOGICAL ENDPOINTS OF IN VITRO ASSAYS 
MTT assay 
The MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide) assay is based on 
the conversion of MTT into formazan crystals by living cells, which determines 
mitochondrial activity. The general purpose of the MTT (3-[4,5-dimethylthiazol-2-yl]-2,5 
diphenyl tetrazolium bromide) assay is to measure viable cells in relatively high throughput 
(96-well plates) without the need for elaborate cell counting. Therefore the most common use 
is to determine cytotoxicity of several drugs at different concentrations. The principle of the 
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MTT assay is that for most viable cells mitochondrial activity is constant and thereby an 
increase or decrease in the number of viable cells is linearly related to mitochondrial activity. 
The mitochondrial activity of the cells is reflected by the conversion of the tetrazolium salt 
MTT into formazan crystals, which can be solubilised for homogenous measurement. Thus, 
any increase or decrease in viable cell number can be detected by measuring formazan 
concentration reflected in optical density (OD) using a plate reader at 540 and 720 nm. For 
drug sensitivity measurements the OD values of wells with cells incubated with drugs are 
compared to the OD of wells with cells not exposed to drugs. The MTT assay is suitable for 
the measurement of drug sensitivity in established cell lines as well as primary cells. For 
dividing cells (usually cell lines) the decrease in cell number reflects cell growth inhibition 
and the drug sensitivity is then usually specified as the concentration of the drug that is 
required to achieve 50% growth inhibition as compared to the growth of the untreated control 
(50% inhibitory concentration, IC50). For primary cells, drug sensitivity is measured as 
enhanced cell kill of treated cells as compared to the loss of cells already commonly seen in 
untreated cells (50% lethal concentration, LC50) (Van Meerloo et al., 2011). 
Many biological experimental readout parameters are based on transmission, i.e., a detector 
measures the quantity of transmitted light at a given wavelength, and this measure is 
translated into an optical density. These systems have been designed for testing transparent 
matter, such as diluted cell lysates and cell culture media, and cannot be applied to optically 
dense materials such as NPs without accurate validation. Normally, NPs do not emit light but 
they can absorb it, thus resulting in optically dense samples. Density depends on their 
chemistry (gold absorbs more light than iron oxide), size (larger NPs absorb more than small 
NPs) and concentration. The optical density due to formazan (which is proportional to the 
number of living cells) can be significantly increased by the presence of NPs, giving the false 
impression of an improved viability and increased proliferation caused by the NPs (Monteiro-
Riviere et al., 2009; Lewinski et al., 2008). In the case of toxic NPs, the decreased formation 
of formazan (due to reduced cell metabolism) could be masked by the NPs optical density, 
providing a false impression of toxicity lack. Small NPs (4-15 nm) of Au, Ag, AgO, Fe3O4, 
CeO2, and CoO, all absorb at the wavelengths used in most biological assay readouts: 340, 
380, 405, 440, 540/ 550 nm. In addition, some NPs can inhibit colour formation, thereby 
mimicking a cytotoxic effect. Indeed, it has been observed that carbon nanotubes can absorb 
formazan and protect it from metabolisation by the cells. The decreased colour formation, due 
to the direct effect of nanotubes on the dye rather than to decreased number of living cells, 
may thus lead to the false interpretation of a cytotoxic effect (Patri et al., 2007; Wörle-
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Knirsch et al., 2006). The best option, when possible, is to remove NPs before performing the 
assay. The appropriate controls, including cell free systems, have to be included to ensure the 
analysis of true NP-induced effects and, whenever it is possible, alternative assays that are not 
based on optical readouts should be used (e.g., flow cytometry, visual counting of dead cells).  
Not only nanoparticles can interfere with the measurement during the readout in the MTT 
assay. Funk and colleagues described that different preparations of serum albumin from 
bovine or human origin can lead to a concentration-dependent increase in the signals of the 
MTT assay; therefore leading to an overestimation of cell numbers and to an underestimation 
of potential cytotoxic effects of compounds to be tested (Funk et al., 2007). Additionally, 
antioxidant such as vitamin E, ascorbic acid and N-acetylcysteine interfere with the MTT 
tetrazolium salt, as suggested by Bruggiser and collaborators, which showed that MTT 
tetrazolium assay may lead to false positive results when compounds with intrinsic reductive 
potential interact with the tetrazolium salt (Bruggiser et al., 2001). 
  
Trypan Blue dye exclusion assay 
The Trypan Blue dye exclusion assay is used to determine the number of viable cells present 
in a cell suspension. It is based on the principle that live cells possess intact cell membranes 
that exclude certain dyes, such as trypan blue, eosin, or propidium, whereas dead cells do not. 
In this test, a cell suspension is simply mixed with dye and then visually examined to 
determine whether cells take up or exclude dye: a viable cell will have a clear cytoplasm 
whereas a nonviable cell will have a blue cytoplasm. Dye exclusion is a simple and rapid 
technique measuring cell viability but it is subject to the problem that viability is being 
determined indirectly from cell membrane integrity. Thus, it is possible that cell viability may 
have been compromised (as measured by capacity to grow or function) even though its 
membrane integrity is (at least transiently) maintained. Conversely, cell membrane integrity 
may be abnormal yet the cell may be able to repair itself and become fully viable. Another 
potential problem is that because dye uptake is assessed subjectively, small amounts of dye 
uptake indicative of cell injury may go unnoticed. In this regard, dye exclusion performed 
with a fluorescent dye using a fluorescence microscope routinely results in the scoring of 
more non-viable cells with dye uptake than tests performed with trypan blue using a 
transmission microscope. A more sophisticated method of measuring cell viability is to 
determine the cell lightscatter characteristics or propidium uptake. However, this technique is 
far more time consuming and is necessary only when precise measurements on the number of 
dead cells in a cell mixture must be obtained. The trypan blue exclusion is used more as a 
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standard method to validate the cell viability data obtained by the above assays than a test to 
determine cell viability. This method involved direct counting of viable cells and hence 
eliminated the possibility of interference from occurring. Hoskins and co-authors used the 
trypan blue to validate the results obtained from three other enzyme activity-based assays, 
founding a large difference between the cell viability data from trypan blue counting and all 
other three, especially those measured by tests which involve cellular redox enzymes 
(Hoskins et al., 2012). In recent years, modern automated instrumentation has been 
introduced to supplement this traditional technique with the efficiency and reproducibility of 
computer control, advanced imaging, and automated sample handling (Louis and Siegel, 
2011). 
 
Cytokinesis-block micronucleus assay 
The cytokinesis-block micronucleus (CBMN) assay is the preferred method for measuring 
MN in cultured human and/or mammalian cells because scoring is specifically restricted to 
once-divided cells. These cells are recognised by their binucleated (BN) appearance after 
inhibition of cytokinesis by cytochalasin-B. Restricting scoring of MN to BN cells prevents 
confounding effects caused by suboptimal cell division kinetics which is a major variable in 
this assay. Over the past 17 years, the CBMN assay has evolved into a comprehensive method 
for measuring chromosome breakage, chromosome loss, nondisjunction, necrosis, apoptosis 
and cytostasis (Fenech, 2000). In combination with the use of centromeric probes or 
kinetochore antibodies, it is also possible to distinguish between chromosome breakage and 
loss as the mechanism of MN formation and to measure malsegregation of chromosomes 
amongst the two nuclei in binucleated cells. However, new developments now indicate that 
this method can also be used to measure nucleoplasmic bridges (NPBs), a biomarker of 
dicentric chromosomes resulting from telomere end-fusions or DNA mis-repair and to 
measure nuclear buds (NBUDs), a biomarker to detect gene amplification and altered gene 
dosage events (Umegaki and Fenech, 2000; Fenech, 2000; Haaf et al., 1999). The significance 
of these developments and the concept of the CBMN assay as a “cytome” assay of 
chromosomal instability are elaborated in the following sections. The “cytome” concept 
implies that every cell in the system studied is scored cytologically for its viability status 
(necrosis, apoptosis), its mitotic status (mononucleated, metaphase, anaphase, binucleated, 
multinucleated) and its chromosomal instability or damage status (presence of MN, NPBs, 
NBUDs and number of centromere probe signals amongst nuclei of binucleated cell if such 
molecular tools are used in combination with the assay). In the CBMN assay, cells that have 
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completed one nuclear division are blocked from performing cytokinesis using cytochalasin-B 
(Cyt-B) and are consequently readily identified by their binucleated appearance. Cyt-B is an 
inhibitor of actin polymerisation required for the formation of the microfilament ring that 
constricts the cytoplasm between the daughter nuclei during cytokinesis (Carter, 1967). The 
use of Cyt-B enables the accumulation of virtually all dividing cells at the binucleate stage in 
dividing cell populations regardless of their degree of synchrony and the proportion of 
dividing cells. 
Micronuclei 
MN are expressed in dividing cells that either contain chromosome breaks lacking 
centromeres (acentric fragments) and/or whole chromosomes that are unable to travel to the 
spindle poles during mitosis. At telophase, a nuclear envelope forms around the lagging 
chromosomes and fragments, which then uncoil and gradually assume the morphology of an 
interphase nucleus with the exception that they are smaller than the main nuclei in the cell, 
hence the term “micronucleus”. MN, therefore, provide a convenient and reliable index of 
both chromosome breakage and chromosome loss. Because MN are expressed in cells that 
have completed nuclear division they are ideally scored in the binucleated stage of the cell 
cycle (Fenech and Morley, 1985; Fenech and Morley, 1986). Occasionally nucleoplasmic 
bridges between nuclei in a binucleated cell are observed. These are probably dicentric 
chromosomes in which the two centromeres were pulled to opposite poles of the cell and the 
DNA in the resulting bridge covered by nuclear membrane. Thus, nucleoplasmic bridges in 
binucleated cells provide an additional and complementary measure of chromosome 
rearrangement. 
Nucleoplasmic bridges 
It has been proposed that NPBs between nuclei in binucleated (BN) cells should also be 
scored in the CBMN assay because they provide a measure of chromosome rearrangement 
which is otherwise not measured in this assay if only MN are scored (Umegaki and Fenech, 
2000). The NPBs are assumed to occur when the centromeres of dicentric chromosomes are 
pulled to opposite poles of the cell at anaphase. It is rarely possible to observe dicentric 
anaphase bridges before the nuclear membrane is formed, because cells proceed through 
anaphase and telophase rapidly, completing cytokinesis and ultimately breakage of the NPB 
when the daughter cells separate. However, in the CBMN assay BN cells with NPBs are 
allowed to accumulate because cytokinesis is inhibited and the nuclear membrane is 
eventually formed around the chromosomes allowing an NPB to be observed. An alternative 
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mechanism for nucleoplasmic bridge formation is due to telomere end-fusions caused by 
telomere shortening but in this case the nucleoplasmic bridge is not necessarily accompanied 
by the presence of an acentric chromosome fragment. The importance of scoring NPBs should 
not be underestimated because it provides direct evidence of genome damage resulting from 
mis-repaired DNA breaks which is otherwise not possible to deduce by scoring MN only 
which could originate from acentric fragments or chromosome loss. Furthermore, following 
radiation challenge or oxidant challenge tests the measurement of NPB could be used to 
identify defects in recombinational DNA-repair pathways or to characterise and differentiate 
between the genotoxic mechanisms of different agents. 
Nuclear buds 
Amplified DNA may be eliminated through recombination between homologous regions 
within amplified sequences forming minicircles of acentric and atelomeric DNA (double 
minutes) which localise to distinct regions within the nucleus or through the excision of 
amplified sequences after segregation to distinct regions of the nucleus. The above suggests 
the hypothesis that the nucleus may have a capacity to sense excess DNA that does not fit 
well within the nuclear matrix indicating a higher order DNA repair or nuclear housekeeping 
process. Shimizu and colleagues  have suggested that the nucleus eliminates excess amplified 
DNA by an active process that concentrates the amplified DNA to a peripheral point in the 
nucleus, following which, this surplus DNA is budded out to form a micronucleus and 
eventually excluded from the cell altogether by extrusion of the micronucleus from the 
cytoplasm leading to the formation of a “mini-cell” (Shimizu et al., 2000; Shimizu et al., 
1998). The process of nuclear budding occurs during S-phase and the NBUDs are 
characterised by having the same morphology as a micronucleus with the exception that they 
are linked to the nucleus by a narrow or wide stalk of nucleoplasmic material depending on 
the stage of the budding process. 
Apoptotic, necrotic and mitotic cells 
Inclusion of necrosis and apoptosis is important for the accurate description of mechanism of 
action and measurement of cellular sensitivity to a chemical or radiation, as well as the 
mitotic status of the cell system. The use of Cyt-B, should make it easier to score apoptotic 
cells because it is expected to inhibit the disintegration of apoptotic cells into smaller 
apoptotic bodies. The latter process requires microfilament assembly, which is readily 
inhibited by Cyt-B (Atencia et al., 1997). 
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Cytokinesis block proliferation index 
The CBPI (cytokinesis block proliferation index) indicates the average number of cell cycles 
per cell during the period of exposure to cytoB, and may be used to calculate cell 
proliferation. The percentage of mono-, bi-, tri-, and multi-nucleated cells is scored and the 
CBPI is calculated as an index of cytotoxicity, by comparing values in the treated and control 
cultures (Fenech, 2007) 
 
The toxicological relevance of the MN test is strong: it covers several endpoints, its 
sensitivity is high, its predictivity for in vivo genotoxicity requires adequate selection of cell 
lines, its statistical power is increased by the recently available high throughput 
methodologies, it might become a possible candidate for replacing in vivo testing, it allows 
good extrapolation for potential limits of exposure or thresholds and it is traceable in 
experimental in vitro and in vivo systems. Implementation of in vitro MN assays in the test 
battery for hazard and risk assessment of potential mutagens/carcinogens is therefore fully 
justified. The MN assay allows detection of both aneuploidogens and clastogens, shows 
simplicity of scoring, is widely applicable in different cell types, is internationally validated, 
has potential for automation and is predictive for cancer (Kirsch-Volders et al., 2011). 
Therefore, the use of CBMN assay expands from the detection of chromosomal damage 
induced by chemicals (Umegaki and Fenech, 2000), as a strong predictor for the cancer risk 
(El-Zein et al., 2006), as a contributor in the dosimetry after radiation exposure (Pejcal et al., 
2011) and as a comprehensive test to detect the DNA damage induced by nanoparticles (Di 
Bucchianico et al., 2013; Migliore et al., 2010). 
Comet assay 
Over the past decade, the comet assay, or single-cell gel electrophoresis (SCGE) has become 
one of the standard methods for assessing DNA damage, with applications in genotoxicity 
testing, human biomonitoring and molecular epidemiology, ecogenotoxicology, as well as 
fundamental research in DNA damage and repair. The assay attracts adherents by its 
simplicity, sensitivity, versatility, speed, and economy. In the 1970s, Peter Cook and 
colleague developed an approach to investigating nuclear structure based on the lysis of cells 
with non-ionic detergent and high-molarity sodium chloride. This treatment removes 
membranes, cytoplasm, and nucleoplasm, and disrupts nucleosomes, almost all histones being 
solubilized by the high salt (Cook et al., 1976). What is left is the nucleoid, consisting of a 
nuclear matrix or scaffold composed of ribonucleic acid (RNA) and proteins, together with 
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the DNA, which is negatively supercoiled as a consequence of the turns made by the double 
helix around the histones of the nucleosome. The survival of the supercoils implies that free 
rotation of the DNA is not possible; Cook and colleagues proposed a model with the DNA 
attached at intervals to the matrix so that it is effectively arranged as a series of loops, rather 
than as a linear molecule. When the negative supercoiling was unwound by adding the 
intercalating agent ethidium bromide, the loops expanded out from the nucleoid core to form a 
“halo”. The first demonstration of “comets” (though they did not use the word) was by 
Östling and Johanson, who described the tails in terms of DNA with relaxed supercoiling and 
referred to the nucleoid model of Cook (Östling and Johanson, 1984). Essentially, the comet 
tail seems to be simply a halo of relaxed loops pulled to one side by the electrophoretic field. 
The procedure of Östling and Johanson was not widely adopted. A few years later, two 
research groups independently developed procedures involving treatment at high pH (Olive et 
al., 1990; Singh et al., 1988). Measuring DNA strand breaks gives limited information. 
Breaks may represent the direct effect of some damaging agent, but they are generally quickly 
re-joined. They may in fact be apurinic/ apyrimidinic sites (i.e., AP sites or baseless sugars), 
which are alkali labile and therefore appear as breaks. Or they may be intermediates in 
cellular repair, because both nucleotide and base excision-repair processes cut out damage and 
replace it with sound nucleotides. To make the assay more specific as well as more sensitive, 
the extra step of digesting the nucleoids with an enzyme that recognizes a particular kind of 
damage and creates a break has been introduced. Thus endonuclease III is used to detect 
oxidized pyrimidines (Collins et al., 1993), formamidopyrimidine DNA glyco– sylase (FPG) 
to detect the major purine oxidation product 8-oxoguanine as well as other altered purines 
(Dusinska and Collins, 1996), T4 endonuclease V to recognize UV-induced cyclobutane 
pyrimidine dimers (Collins et al., 1997), and Alk A incises DNA at 3-methyladenines (Collins 
et al., 2001). In each case, the enzyme-sensitive sites converted to additional DNA breaks 
increase tail intensity. The comet assay has achieved the status of a standard test in the battery 
of tests used to assess the safety of novel pharmaceuticals or other chemicals  (Hartmann et 
al., 2003) and it is used also to test the genotoxic capacity of nanoparticle on different in vitro 
and in vivo systems.  
The comet assay is also of the most versatile methods for studying DNA repair capacity. 
DNA repair capacity is an important factor, but there are many other intervening processes 
between the incidence of the damage and its manifestation as disrupted cell division. 
Antioxidant enzymes, cell cycle progression, and apoptosis can all play a role, depending on 
the nature of the damaging agent. Using the comet assay, it is possible to measure the actual 
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in vivo damage remaining at intervals after treatment, and thus to study the kinetics of repair 
(Saha et al., 2008; Palyvoda et al., 2003). 
Unfortunately, in case of in vitro experiments, there are more problems to solve, thus it is 
complicated to perform, requiring hours of cell culture and sampling at several intervals for 
comet assay analysis. It is possible that results might vary according to subtle differences in 
culture conditions from day to day. Finally, as explained above, interpretation can be difficult, 
especially if the damaging agent induces different amounts of lesions in different subjects. 
An alternative approach is to measure the potential for DNA repair in a cellular (or nuclear) 
extract, by assessing repair enzyme activity in a biochemical assay. The extract is provided 
with a substrate of DNA containing specific lesions, and as an indicator of repair either DNA 
breaks (the common repair intermediate) or repair DNA synthesis are measured over a 
standard incubation time. The substrate can be an oligonucleotide containing specifically 
altered bases, tagged with either a radioactive or a fluorescent label; nicking at the lesion 
results in a change in size of the labelled fragment, usually detected on the basis of 
electrophoretic migration (Paz-Elizur et al., 2007). In a modification of this assay  
oligonucleotides containing different lesions are immobilised as a micro-array; activity is 
assessed as loss of fluorescence, and several repair pathways are measured simultaneously in 
one sample extract applied to the array of substrates (Sauvaigo et al., 2004). 
Talking about in vivo studies, there are numerous reports linking polymorphisms in DNA 
repair genes with the level of damage of different kinds in exposed populations, and 
presumably the change in the damage level results from an altered repair activity. Ryk and 
collaborators looked at the impact of variation in 6 repair related genes (APE1, XRCC1, 
XRCC3, MLH1, XPD and NBS1) on repair of MMS-induced alkylation damage, using the 
comet assay on stimulated lymphocytes from 52 healthy subjects. SBs were at their highest 
just after MMS treatment, and the level steadily declined over 2-h incubation. The variant 
alleles of APE1, whose product catalyses the strand breakage step at apurinic/apyrimidinic 
(AP-) sites left after glycosylase action in BER, and of NBS1 and XRCC3 (with a role in 
homologous recombination at double SBs) were associated with high levels of SBs at early 
time points. MMS is not known as a direct strand-breaking agent, but SBs (including alkali-
labile AP-sites) appear during repair of alkylation damage. A possible explanation of the 
effect of the APE1 variant is that a reduced activity of this enzyme would lead to an 
accumulation of its substrate, namely the AP-sites left by OGG1 action (Ryk et al., 2008). 
Previously, Vodicka and co-authors showed the effect of the XRCC1 polymorphism 
(Arg399Gln), as well as a variant in the APE1 gene (Asn148Glu), on SB repair. These 
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polymorphisms in combination, as well as additional XRCC1 SNPs, had increasing effects on 
repair rates. They also identified a decrease in repair of 8-oxoG (in the in vitro OGG assay) 
associated with the presence of a homozygous variant hOGG1 allele (Ser326Cys). The APE1 
SNP had an effect in combination with the variant form of hOGG1 (Vodicka et al., 2007). 
This could be a possible explanation for the different results we observed when we perform 
comet assay on different volunteers. Contrarily, experiments in which repair is measured with 
the comet assay have shown correspondingly poor association between gene expression and 
enzyme activity (Riso et al., 2010; Danielsen et al., 2008). 
FISH analysis 
Fluorescence in situ hybridization (FISH) is a versatile technique that allows visualization of 
nucleic acid sequences in their native context at the single cell level. FISH can be performed 
on a variety of targets, including RNA within cells, DNA in metaphase chromosome 
preparations obtained from mitotic cells, or DNA in interphase nuclei from cells in the non-
mitotic phases of the cell cycle. FISH has been widely used for research applications, 
including physical mapping, studies of biological processes such as DNA replication, RNA 
processing, and gene expression, and studies of chromosome evolution, including 
conservation of sequences and chromosome rearrangements between species. In the clinical 
laboratory, FISH has become not only an indispensable adjunct to banded chromosome 
analysis, but also a stand-alone method for the detection and characterization of both 
constitutional and acquired chromosomal abnormalities. The basic elements of the FISH 
procedure include selection of probe(s) for sequence that is complementary to the target of 
interest, probe labelling, slide preparation, slide pre-treatment, denaturation of probe and 
target, hybridization, washing, analysis, and interpretation. For genomic DNA analysis, FISH 
probes can target unique DNA sequences, repetitive DNA sequences, entire chromosome 
arms or whole chromosomes. Unique sequence probes are useful for identifying gains and 
losses of specific genes or genomic regions, as well as genomic rearrangements, such as 
translocations. Repetitive sequence probes are primarily used for interrogating centromeric or 
pericentromeric regions. Probes that hybridize along the length of entire chromosome arms or 
whole chromosomes, also known as chromosome paints, can be used to confirm or further 
characterize chromosomal rearrangements identified by banded chromosome analysis. FISH 
probes can be labelled either by incorporation of biotin or digoxigenin-conjugated nucleotides 
into the probe with subsequent detection using a fluorescently labelled antibody (indirect 
method), or by incorporation of fluorophore-conjugated nucleotides (direct method). Probes 
used in clinical laboratories are currently labelled using the direct method because fewer steps 
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and less time are involved in performing tests using these probes. Indirect labelling may also 
produce more background from nonspecific antibody binding. However, indirect labelling 
allows for more flexibility, because different fluorophores can be attached to the detection 
antibody for the same indirectly labelled probe, and multiple rounds of detection with 
antibody can be performed for signal amplification. The FISH procedure varies depending on 
specific applications and specific techniques exist with some variables. 
Combined with FISH with probes for centromeric, pericentromeric or telomeric regions, 
micronucleus scoring in the cytokinesis-block method allows the identification of the major 
mechanisms responsible for micronucleus induction: chromosome breakage leading to MN 
with acentric fragments and failure of the mitotic apparatus resulting in MN with entire 
chromosomes. MN arising from lagging chromosomes can be identified with 
immunochemical labelling of kinetochores proteins that are assembled on centromeres or by 
the presence of centromere- specific DNA using FISH. MN that do not contain kinetochore 
proteins or centromeric DNA sequences are interpreted as harbouring acentric chromosomal 
fragments (Albertini et al., 2000). However, the use of antikinetochore antibodies does not 
distinguish between unique chromosomes and MN formed from entire chromosomes with 
disrupted or detached kinetochore which may result in MN with no kinetochore signal. 
Furthermore, chemicals can interact with the synthesis of kinetochore proteins. Therefore, the 
preferred method is to use FISH with pancentromeric probes to identify MN containing whole 
chromosomes. In addition, centromeric chromosome-specific probes also allow an accurate 
analysis of non-disjunction (unequal distribution of unique homologous chromosome pairs in 
the daughter nuclei).  
In the past, several attempts have been made to distinguish between the aneuploidogenic and 
clastogenic action of test compounds. The first approach was based on measuring the 
diameter of MN. It was assumed that the loss of whole chromosomes induced by 
aneuploidogens would result in larger MN than those induced by clastogens, which generate 
only chromosomal fragments (Hoegstedt and Karlsson, 1985; Yamamoto and Kikuchi, 
1980;). This method seemed to be applicable, but it was very time consuming and was subject 
to difficulties in species with karyotypes that include chromosomes of very different size 
(Rosefort et al., 2004). Nowadays, the FISH analysis allows to detect MN with or without 
probe signalling in a fast but expensive way. 
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AIM OF THE STUDY 
This PhD thesis is placed inside the European project “The Reactivity and Toxicity of 
Engineered Nanoparticles: Risks to the Environment and Human Health” also known as 
“NanoReTox”. NanoReTox intends to examine the molecular and cellular reactivity of well 
characterised nanoparticles on a panel of primary human/mammalian cells and human cell 
lines originating from different target organs and exposure routes as an indicator of in vivo 
toxicity. The aim is to discover which features of nanoparticles confer reactivity with which 
cell types/target organs. Among all the work packages (WP) present in this project, the WP5 
and WP6 are the ones included in this PhD work. WP5 aims to investigate the cellular and 
molecular reactivity of the selected metal nanoparticles in a) primary mammalian and human 
cells and b) in a panel of established human cell lines. The chosen cells will reflect likely 
nanoparticle exposure routes. The primary cell work will be performed on lung and skin 
models. State of the art fixed and live cell microscopy is used to study particlecell-
interactions; air-liquid interface models are used for lung epithelial cells. WP6 aims to 
investigate the possible genotoxic and carcinogenic effects in chosen in vitro models due to 
NPs exposure. Particularly, this PhD work was focussed on cytotoxic and genotoxic effects 
induced by some metal nanoparticles in two different cell systems:  murine alveolar 
macrophage cells (Raw 264.7) and human peripheral blood lymphocytes (PBL). Since PBL 
are present in the circulatory system, primary cultures of human PBL are representative of a 
major pathway of NPs distribution in the whole organism. Raw 264.7 cells (murine alveolar 
macrophage lineage) are considered a representative model for the study of lung responses 
(inflammatory processes) to inhaled nanoparticles and ultrafine particles. Moreover, the 
possible mechanisms of action in the induction of cell damage was analysed through specific 
assays.  
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MATERIALS AND METHODS 
We analysed the cytotoxic effects of metallic nanoparticles in human peripheral blood 
lymphocytes in PHA stimulated whole blood cultures (PBL) and in murine macrophage cell 
line Raw 264.7. 
Nanoparticles set 
The tested NPs (Table I) have been synthetized by partners of the NanoReTox project: Intrisiq 
Material Ltd, Joint Research Centre (Ispra, Italy), Natural History Meseum (London, UK) and 
Imperial College (London, UK). The NPs characterization has been performed in the 
corresponding laboratories. All the NPs samples were supplied in suspensions, except for the 
CuO commercial which was in powder form. 
 PARTICLE SIZE SUPPLIER ABBREVIATION 
1 CuO commercial 10-100 nm INTRINSIQ LTD CuO INT 
2 CuO spheres 7 nm NHM Spheres 
3 CuO spindles 30x270x1200 nm  NHM Spindles 
4 CuO rods 7x40 nm NHM Rods 
5 AuNP 5 nm JRC Au5 
6 AuNP 15 nm JRC Au15 
7 AuNP 40 nm JRC Au40 
8 AgNP 20 nm JRC Ag20 
9 AgNP 40 nm JRC Ag40 
10 AgNP 95 nm JRC Ag95 
11 AgNP PVP-capped 10 nm IMPERIAL Ag10-PVP 
12 SiO2-Ru(bypy)2 25 nm JRC SiO2-25 
13 SiO2-Ru(bypy)2 50 nm JRC SiO2-50 
14 
SiO2-Ru(bypy)2  
after amination and 
redispersion at  pH 
3.4 
50 nm JRC SiO250-AM 
Table I. Nanoparticle set used in the work. 
 
 
 
38 
 
Cell Cultures and Exposure to NPs 
Raw 264.7 cells were purchased from the Istituto Zooprofilattico of Brescia (Italy). The cells 
were cultured in minimal essential medium (CELBIO, Milan, Italy) supplemented with 10%, 
heat inactivated, foetal bovine serum (CELBIO, Milan, Italy), 1% penicillin/streptomycin 
(CELBIO), and 1% L-glutamine (CELBIO). The cell cultures were maintained in a 
humidified atmosphere (5% CO2) at 37°C. After 24h of incubation, the cell cultures were 
treated with different mass concentrations of NPs. The study was also performed on human 
peripheral blood lymphocytes of healthy male volunteers. Approximately 4–6 ml of blood 
was drawn by venipuncture in Li-heparin vials, according to standard procedure. The donors 
were chosen according to the following criteria: male, young age, non-smokers, without 
pharmacological treatments for at least 3 weeks before donation and without any radiological 
examination performed within the previous 3 months. Blood was drawn from the volunteers 
and 600 μl of whole blood was used to prepare two paired independent lymphocyte cultures 
for each subject in 4.7 ml of complete medium per culture. Standard medium was prepared 
with RPMI 1640 (Gibco BRL, Italy) supplemented with 10%, heat inactivated, foetal bovine 
serum (Gibco BRL), 1.5% phytohaemagglutinin (Gibco BRL) and 1% penicillin–
streptomycin (Gibco BRL).  
The mass concentration ranges used for testing NPs cytotoxicity was 0.1-100 µg\ml for CuO 
NPs, Au NPs and SiO2 NPs, while for Ag NPs it was 0.001-1  µg\ml. Genotoxic assay was 
performed on the same range, except when the lowest dose showed slight cytotoxicity or 
highest concentration showed a great cytotoxicity: in those cases, the range was restricted. 
 
MTT Assay 
Cytotoxicity was assessed by using 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium 
bromide (MTT) assay. Mitochondrial dehydrogenases of viable cells reduce MTT to water 
insoluble blue formazan crystals which are then solubilised by dimethyl sulfoxide (DMSO); 
this assay thus indicates cell mitochondrial activity impairment. Raw 264.7 cells were grown 
to sub-confluence in 96-well plates before being exposed to NPs suspensions for 2 and 24h. 
Hydrogen peroxide (H2O2) (10 μM) was used as a positive control. Whole blood cultures 
were carried out as above described and treated with the same conditions of adherent cells. 
We collected the cells (3000 rpm, 5 min) and suspended them in 0.5 ml of complete medium. 
3.5 ml of Erythrocyte lysis buffer (155 mM NH4Cl 10 mM KHCO3 1 mM Na2EDTA pH 7.4) 
were added and after 1.5 min we collected the cells (3000 rpm, 5 min). The cells were washed 
in 3.5 ml of complete medium once and then pelleted (3000 rpm, 5 min). The obtained pellet 
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was suspended in 3.5 ml of complete medium and then we putted 100 μl of the cell 
suspension in a 96-well plate. After exposure of all cell types (nine wells for each condition), 
10 μl of a 5mg\ml MTT solution were added. After 3 h at 37 °C, medium in adherent cell 
culture was then replaced by 100 μl of DMSO and mixed thoroughly to dissolve the formazan 
crystals; to cell culture in suspension 100 μl of DMSO were added without discarding the 
medium. To limit potential interactions due to the possible presence of residual NPs that 
could interfere with the assay, in parallel cultures without cells (blank) were used to take into 
account the absorption due to nanoparticles. Then, absorbance was measured at 570 nm 
(630nm background) and cell viability was determined as a percentage of the negative control 
(unexposed cells) minus the percentage of concurrent condition blank absorbance.  
Trypan blue dye exclusion assay 
Trypan blue dye exclusion assay is used to determine the number of viable cells present in a 
cell suspension, based on the principle that live cells possess intact cell membranes that 
exclude the Trypan blue dye. Briefly, Raw 264.7 cells were grown to sub-confluence in 6-
well plates before being exposed to NPs suspensions for 2 and 24h. Hydrogen peroxide 
(H2O2) (10 μM) was used as a positive control. Whole blood cultures were carried out as 
above described and treated with the same conditions of adherent cells, then collected as 
described for the MTT assay. After exposure of all cell types,  the cells were collected and 10 
μl  of cell suspension were diluted in appropriated volume of Trypan blue dye and re-
suspended. 10 μl of this solution were putted inside a Burker’s chamber and counted manually 
at the inverted microscope. The number of viable cells was calculated through this formula:  
Number of cells viable per field counted\ Number of field counted * dilution factor * 10
4
  
Cell number was expressed as the percentage of viable cells in the treated cultures in 
comparison with the control cultures. These assays reflect all treatment-related effects 
(necrosis, cell cycle delay, and apoptosis) that reduce the number of viable cells. 
Cytokinesis-block micronucleus cytome assay 
The cytokinesis-block micronucleus cytome assay (CBMN Cyt) on whole blood treatments 
was performed according to the procedure described by Migliore and co-authors (Migliore et 
al., 2010; Migliore et al., 2002). After 24h of culture, the cells were exposed to NPs at 
concentrations determined. 0.17 μg\ml mitomycin C (MMC, Kyowa Hakko Kogyo Co., 
Tokyo) was used as positive control. Cytochalasin B (6 μg\ml) was added after 44h to block 
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the cytokinesis process, and lymphocyte cultures were harvested after 72h. Cells were then 
treated with an hypotonic solution (0.075 M KCl) to lyse erythrocytes for 2 min, prefixed in 
3:5 methanol:acetic acid, washed once with methanol and subsequently fixed twice with a 6:1 
methanol:acetic acid fixative solution. Finally, the cell solution was dropped onto cold glass 
slides. The staining procedure was performed by immersing the air-dried slides in a 2% 
Giemsa solution in Sorensen’s buffer (pH=6.8). To assess the genotoxic effects of NPs in 
Raw 264.7 cells, the CBMN Cyt assay was performed as follows. Briefly, making the 
appropriate dilutions, a suitable quantity of cells (2x10
4
 cells) was seeded into six-well plates, 
and two paired, independent cultures for each concentration were prepared. After 24h, the 
macrophages were treated with the NPs as described earlier. Mitomycin C 0.17 μg\ml was 
used as a positive control. Forty-four hours after the initial preparation of the cultures, 
cytochalasin B was added to each test well to a final concentration of 4 μg\ml to block 
cytokinesis of dividing cells. Cell cultures were then harvested after 28h and treated as 
described earlier. Two thousand binucleated cells were examined for each experimental point 
in a blind mode (1,000 from each independent culture replicate) using a Nikon Eclipse 800 
optical microscope (final magnification of 400x). The scoring criteria adopted by Fenech were 
followed (Fenech, 2007). We evaluated the binucleate micronucleated cells frequency as 
number of binucleate cells containing one or more micronuclei/1,000 binucleated cells and the 
total number of micronuclei in 1,000 binucleated cells. Moreover, 500 cells were scored to 
evaluate the percentage of mono-, bi-, tri-, and multi-nucleated cells, and the CBPI 
(cytokinesis block proliferation index) was calculated as an index of cytotoxicity by 
comparing values in the treated and control cultures. The CBPI indicates the average number 
of cell cycles per cell during the period of exposure to cytoB, and may be used to calculate 
cell proliferation. Finally, other damage events were scored in once-divided binucleated cells 
per 1000 cells, namely: (a) nucleoplasmic bridges, a biomarker of DNA misrepair and/or 
telomere end-fusions and (b) nuclear buds, a biomarker of elimination of amplified DNA 
and/or DNA repair complexes. The number of apoptotic, necrotic and mitotic cells per 500 
cells was also evaluated. 
Fluorescence in situ hybridization 
Separate slides from CBMN Cyt were used to achieve the fluorescence in situ hybridization 
with human and murine pancentromeric probes (Kreatech Diagnostics, Netherlands). Slides of 
NPs treatments, positive and negative control were examined for the presence of centromeric 
spots in MN and were classified as centromere positive (MN C+) and centromere negative 
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(MN C-). Slides were pre-treated in 2x standard saline citrate (SSC)/0.5% Igepal, pH 7.0, at 
37°C for 15 min and dehydrated in a graded ethanol series (70, 85 and 100%); slides and 
probes were co-denatured for 10 min at 75°C and overnight at 37°C on a humidified chamber.  
Post-hybridization washing was performed in 1x washing buffer (0.4xSSC/0.3% Igepal) for 2 
min at 72°C. Afterwards slides were washed in 2xSSC/0.1% Igepal for 1 min at room 
temperature and dehydrated in a graded ethanol series (70, 85, 100%) for 1 min each. The 
slides were counterstained with DAPI (0.1 μg\ml). For FISH analysis 500 binucleated cells 
(BN) were scored per culture. The MN in BN were examined using the same scoring criteria 
described previously for the CBMN Cyt assay. The preparation was examined with a Nikon 
Eclipse 800 microscope (final magnification of 400x) equipped with a 100W mercury lamp 
and triple band-pass filters (DAPI/FITC/Texas Red or DAPI/FITC/Rhodamine) are used to 
view multiple colours and single band-pass filters are used for individual colour visualization. 
Comet Assay and oxidative DNA damage 
The modified alkaline comet assay (Collins et al., 1996) was carried out on Raw 264.7 cell 
cultures seeded at a concentration of 10
4
 cells in six well plates. After attachment, cells were 
treated with NPs at different concentrations. In whole blood cultures, after 24h from the 
beginning of culture, the cells were exposed to the same concentrations of NPs. In all cell 
cultures 10 μM hydrogen peroxide was used as a positive control. At least two independent 
experiments were performed for each concentration tested and incubation was performed for 
2 or 24h. After treatment, the cell pellet was used for the comet assay. Briefly, the slides were 
spread with 1% normal melting agarose (Sigma-Aldrich) in PBS (Sigma-Aldrich) and left to 
solidify at 37°C. Cell pellets were suspended in 85 μl of 0.5% low-melting agarose (Agarose 
wide range, Sigma-Aldrich) in PBS at 37°C, and two slides per culture were prepared. The 
cell suspension was dropped on top of the first agarose layer, covered with a coverslip, and 
allowed to solidify at 4°C. A final layer of 0.5% low-melting agarose was then added to the 
slide. The lysis procedure was performed in cold lysis buffer (2.5 M NaCl, 100 mM 
Na2EDTA, 10 mM Tris, 10% DMSO, and 1% Triton X-100, pH 10.0) for at least 1h at 4°C. 
The slides were then placed for 20 min in alkaline buffer (300 mM NaOH, 1 mM Na2EDTA, 
pH > 13.0), and electrophoresed for 20 min at 25 V adjusted at 300 mA. The slides were 
neutralized in 0.4 M Tris buffer, pH 7.5, for 5 min, twice and in methanol absolute for 5 min, 
once. Coded slides were scored after staining with ethidium bromide (20 μg\ml) using a 
fluorescence microscope (Nikon Eclipse E800) at 200x magnification. The percentage of 
DNA in the comet tail in a total of 100 randomly selected cells per sample (two replicates, 
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each with 50 cells/slide) was used as a measure of the amount of DNA damage. Analysis was 
carried out by using a Comet Image Analysis System, version 5.5 (Kinetic Imaging, 
Nottingham, UK). Results were reported as % DNA in tail. To determine the presence of 
oxidized pyrimidine and purine bases, specific bacterial enzymes, namely endonuclease-III 
(Endo III) and formamidopyrimidine-DNA glycosylase (Fpg), were used respectively. Two 
independent experiments were performed at 2 and 24h treatment. Before electrophoresis, the 
slides were washed with enzyme buffer (3.72x10
-3
 g\ml Na2EDTA (Carlo Erba, Milan, Italy), 
7.45x10
-3
 g\ml KCl (Carlo Erba, Milan, Italy), 2.38x10
-3 
g\ml  HEPES (Sigma-Aldrich, St. 
Louis, MO), and 1x10
-3
 g\ml BSA (Sigma- Aldrich, St. Louis, MO)(only for the Fpg enzyme) 
three times for 5 min each at 4°C. Next, 100 μl of either buffer alone (reference slides) or 100 
μl with 0.2 units of Endo-III or 100 μl with 0.5 units of Fpg (Trevigen, Gaithersburg, USA) 
was applied to each slide, which was subsequently covered with a coverslip and incubated at 
37°C for 45 min (EndoIII) or 30 min (Fpg) in humidified chambers. After the treatment, 
slides were placed in a horizontal electrophoresis chamber, and electrophoresis was 
performed as described earlier. To detect oxidized purines or pyrimidines, slides were 
incubated without enzymes (i.e., only buffer) and compared to those incubated with Fpg or 
Endo III enzymes, respectively. To determine the number of enzyme-sensitive sites, the 
difference between the value of the % DNA in tail obtained after digestion with each enzyme 
and with the buffer only was calculated.  
Statistical Analysis 
All results are expressed in terms of the mean and standard error of the mean for two 
independent duplicated experiments, except where it is differently indicated. The statistical 
significance of the results was calculated using Student’s t Test. The level of significance was 
set at P < 0.05. A linear regression equation was used to calculate the effect of mass 
concentration on each endpoints. All statistical analyses were performed using 
STATGRAPHICS Plus (SGWIN, version 2.1).  
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RESULTS 
Copper oxide nanoparticles 
MTT assay 
MTT assay was performed with 0.1, 1 and 10 μg\ml of CuO NPs (Fig.4). CuO NPs exposure 
(2h treatments) at the lowest tested concentrations has led to a reduction in cell viability more 
evident for nanomaterials with smaller dimensions (spheres) in both cell systems. The CuO 
spindles (the largest dimension), however, generally showed a cytotoxicity trend in a dose-
dependent and  statistically significant manner for Raw 264.7 cells. In peripheral blood 
lymphocytes dose-dependent trends were observed for the CuO spheres. After 24h exposure, 
the two cell types showed a slightly different sensitivity only to CuO spheres except for the 
highest dose of CuO rods and CuO INT. Phagocytic cells showed a dose-dependent 
cytotoxicity trend both after CuO spheres exposure, CuO spindles and CuO rods, with spheres 
and rods treatments the most effective. The highest tested concentrations of spheres, spindles 
and rods were the most effective in inducing cytotoxicity also in exposed blood cultures. 
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Figure 4. Effects of CuO NPs treatments on the viability of Raw 264.7 and whole blood by MTT assay. Cell 
viability was assessed by MTT assay and results are presented as a percentage of negative control viability. C+: 
10µM H2O2. Cells were treated with the indicated concentrations of CuO NPs for 2h (above) and 24h (bottom). 
Statistically significant differences from the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; 
***p < 0.001). Each data represent the mean of two separate experiments and error bars represent the standard 
error of the mean. (2h treatment). In Raw 264.7 CuO spindles showed a dose-effect relationship (r= -0.92; R
2
= 
84%; P= 0.03) as well as CuO spheres in PBL (r=-0.97; R
2
= 94.3%; P= 0.006) (24h treatment). In Raw 264.7 
CuO spheres showed a dose-effect relationship (r= -0.94; R
2
= 89.2%; P= 0.015) as well as CuO spindles (r= -
0.92; R
2
= 85.3%; P= 0.025) and CuO rods (r=-0.92; R
2
= 83.8%; P= 0.03). 
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Trypan blue dye exclusion 
Trypan blue dye exclusion was performed with 0.1, 1 and 10 μg\ml of CuO NPs (Fig.5). 2h 
CuO NPs exposure at lowest tested concentrations has led to a reduction in cell viability more 
evident for nanomaterials with smaller dimensions (spheres) in both cell systems. The CuO 
spindles (the largest dimension), however, showed a greater cytotoxicity at the highest doses 
for Raw 264.7 cells. In peripheral blood lymphocytes, the CuO spheres exerted the greater 
toxicity, followed by CuO spindles. After 24h exposure, the two cell types showed a different 
sensitivity to CuO NPs, especially for spindles and rods. All the CuO NPs showed a dose-
dependent cytotoxicity trend both in phagocytic cells and in lymphocytes, except for 2h CuO 
spindles treatment in Raw 264.7. 
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Figure 5. Effects of CuO NPs treatments on the viability of Raw 264.7 and whole blood by Trypan blue dye exclusion. 
Results are presented as a percentage of negative control viability. C+: 10µM H2O2. Cells were treated with the indicated 
concentrations of CuO NPs for 2h (a) and 24h (b). Statistically significant differences from the control were determined by 
Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). Each data represent the mean of two separate experiments and error 
bars represent the standard error of the mean (2h treatment). In Raw 264.7, CuO spheres showed a dose-effect relationship 
(r= -0.95; R2= 89.8%; P= 0.004) as well as CuO rods (r=-0.98; R2= 95.7%; P= 0.004) and CuO INT (r=-0.99; R2= 97.6%; P= 
0.002) in Raw 264.7, while in PBL all the CuO NPs showed a statistically significant linear correlation  (CuO spheres: r= -
0.99; R2= 97.7%; P= 0.002; CuO spindles: r= -0.98; R2= 95.8%; P= 0.004; CuO rods: r= -0.95; R2= 90.2%; P= 0.013; CuO 
INT r= -0.98; R2= 95.8%; P= 0.004) (24h treatment). All tested CuO NPs showed a dose-effect relationship in Raw 264.7 
(CuO spheres: r= -0.95; R2= 90.6%; P= 0.0034; CuO spindles: r= -0.93; R2= 86.5%; P= 0.007; CuO rods: r= -0.97; R2= 
93.4%; P= 0.0017; CuO INT r= -0.97; R2= 94.3%; P= 0.0012) as well in PBL ( CuO spheres: r= -0.98; R2= 96%; P= 0.0034; 
CuO spindles: r= -0.99; R2= 98.7%; P= 0.0007; CuO rods: r= -0.95; R2= 90%; P= 0.014; CuO INT r= -0.96; R2= 92.3%; P= 
0.009). 
 
 
47 
 
CBMN cytome assay 
CBMN cytome assay was performed with 0.1, 1 and 10 μg\ml of CuO NPs. Table II 
summarizes the results of cell proliferation and cytostasis measured by scoring the CBPI and 
mitotic, apoptotic and necrotic indices after CuO NPs exposure. All doses in both cell systems 
reduce the proliferation index in a statistically significant manner. A linear relationship was 
found for the CBPI of CuO INT exposed Raw 264.7 cells while exposed lymphocytes 
revealed a decrease of mitotic figures in a dose-related manner for all the CuO NPs tested. 
Exposure to CuO NP caused apoptotic responses measured by apoptotic figures scored in 
CBMN Cyt assay. Programmed cell death was increased to 2.5 fold (CuO spindles and rods) 
in macrophages and up to 4.5 fold in lymphocytes (CuO INT) while severe necrotic responses 
were observed in Raw 264.7 cells but not in exposed whole blood. Consistent with the 
inhibition of proliferation, an inhibition of mitotic index was observed in both studied cellular 
systems.  
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Table II. CBPI, mitotic, apoptotic and necrotic indices scored by CBMN Cyt assay. Statistically significant 
differences from the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). Each 
data represent the mean of two separate experiments ± the standard error of the mean. Linear regression for 
CBPI in Raw 264.7: CuO INT r= -0.99; R
2
= 97.7%; P= 0.011. Linear regression for mitotic index in PBL: CuO 
spheres r= -0.98; R
2
= 95.1%; P= 0.025; CuO spindles r= -0.99; R
2
= 98%; P= 0.01; CuO rods r= -0.99; R
2
= 
99.6%; P= 0.002; CuO INT r= -0.99; R
2
= 99.8%; P= 0.0008. Linear regression for apoptotic index in Raw 
264.7: CuO rods r= 0.96; R
2
= 92.5%; P= 0.038. Linear regression for apoptotic index in PBL: CuO spindles r= 
0.96; R
2
= 94%; P= 0.036; CuO rods r= 0.98; R
2
= 96.2%; P= 0.019; CuO INT r= 0.99; R
2
= 98.2%; P= 0.009. 
Linear regression for necrotic index in Raw 264.7: CuO spheres r= 0.999; R
2
= 99.9%; P= 0.0001; CuO spindles 
r= 0.97; R
2
= 93.8%; P= 0.03; CuO rods r= 0.99; R
2
= 98.5%; P= 0.007. Linear regression for necrotic index in 
PBL: CuO spheres r= 0.97; R
2
= 96.6%; P= 0.034; CuO INT r= 0.98; R
2
= 96.9%; P= 0.016. 
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Figure 6 shows the micronuclei frequency obtained by treating Raw 264.7 cells and blood 
cultures with different mass concentrations of CuO NP suspensions. The frequency of 
micronuclei is much higher in phagocytic cells compared to lymphocytes except for exposure 
to CuO INT, where the highest tested concentration induced a greater micronuclei formation 
in lymphocytes. A linear relationship was found in the MN induction by CuO spheres and 
spindles treatments in Raw 264.7 and by CuO spindles, rods and INT treatments in 
lymphocytes. 
 
Figure 6. Micronuclei frequency determined by CBMN Cyt assay in Raw 264.7 and PBL from whole blood 
after CuO NPs exposure at indicated mass concentrations (µg\ml). C+, 0.17 µg\ml mitomycin C. Statistically 
significant differences from the control were determined by Student’s test (*p < 0.05; **p < 0.01; ***p < 0.001). 
Raw 264.7 CuO spheres treatment showed a dose-effect relationship (r= 0.96; R
2
= 92.5%; P= 0.009) as well as 
the CuO spindles exposure (r= 0.89; R
2
= 79.6%; P= 0.042). PBL CuO spindles treatment showed a dose-effect 
relationship (r= 0.85; R
2
= 72.8%; P= 0.05) as well as both CuO rods (r= 0.95; R
2
= 90.4%; P= 0.045) and CuO 
INT (r= 0.91; R
2
= 84.5%; P= 0.027) exposures. 
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The induction of nucleoplasmic bridges formation (Fig.7) was greater in Raw 264.7 cells than 
in PBL after CuO spheres and rods exposure, while the frequency was comparable with the 
two cell systems after CuO spindles and INT treatments. Lymphocytes showed a major 
sensitivity at the lowest doses of CuO INT respect to phagocytic cells. Moreover, in Raw 
264.7 spheres and rods showed a significant dose-dependent increase in NPB frequency as 
well as spindles, rods and INT in lymphocytes cultures. 
 
Figure 7. Nucleoplasmic bridges frequency determined by CBMN Cyt assay after CuO NPs exposure at 
indicated mass concentrations (µg\ml). C+, 0.17 µg\ml mitomycin C. Statistically significant differences from 
the control were determined by Student’s t-test (**p < 0.01; ***p < 0.001). Raw 264.7 CuO spheres treatment 
showed a dose-effect relationship (r= 0.87; R
2
= 76.4%; P= 0.05) as well as CuO rods exposure (r= 0.99; R
2
= 
99.6%; P= 0.002). PBL CuO spindles treatment showed a dose-effect relationship (r= 0.95; R
2
= 90.1%; P= 
0.012) as well as both CuO rods (r= 0.96; R
2
= 91.3%; P= 0.044) and CuO INT (r= 0.96; R
2
= 92.2%; P= 0.04) 
exposures. 
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Nuclear buds (NBUD) were significantly generated in Raw 264.7 after exposure to NPs at any 
doses, except for the lowest doses of CuO INT (Figure 8).  In lymphocytes, only spheres and 
INT caused an induction of NBUD formation, with the first the most effective at the lowest 
dose and the second at the highest dose. A dose-effect relationship was found in Raw 264.7 
after CuO spindles treatment and in  PBL after CuO rods exposure. 
 
Figure 8. Nuclear Bud frequency determined by CBMN Cyt assay after CuO NPs exposure at indicated mass 
concentrations (µg\ml). C+, 0.17 µg\ml mitomycin C. Statistically significant differences from the control were 
determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). Raw 264.7 CuO spindles treatment showed 
a dose-effect relationship (r= 0.91; R
2
= 83%; P= 0.032). PBL CuO rods treatment showed a dose-effect 
relationship (r= 0.99; R
2
= 98.5%; P= 0.007). 
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Primary and oxidative DNA damage 
Comet assay was performed with 0.1, 1 and 10 μg\ml of CuO NPs. Figure 9 shows data 
obtained in evaluating the CuO NP-induced DNA damage by the comet assay. Increase in 
DNA migration (i.e., primary DNA damage) was significantly detected after 2 and 24h 
treatments. Comparing the two cell systems, it is evident that they react differently to NP 
treatments. Significant trends were found in PBL (2 and 24h) while the Raw 264.7 cells 
showed a dose-dependent effect only after the short treatment. CuO INT exposures were the 
most effective in inducing DNA fragmentation after 2h exposure both in Raw 264.7 and PBL 
(about 4.5-fold and 6-fold higher than in untreated control, respectively) while CuO INT and 
rods were the most effective after 24h exposure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
53 
 
 
Figure 9. Primary DNA damage. Comet assay revealed an increase in primary DNA damage, with different 
sensitivity shown by cell types at 2h (above) and 24 h (bottom) treatment. C+: 10 µM H2O2. 2h CuO spheres 
treatment in Raw 264.7 showed a dose-effect relationship (r= 0.95; R
2
= 90.7%; P= 0.04) as well as in CuO 
spindles (r= 0.99; R
2
= 97.6%; P= 0.01), rods (r= 0.99; R
2
= 97.4%; P= 0.01) and CuO INT (r= 0.99; R
2
= 98.6%; 
P= 0.007) exposures. CuO spindles (2h treatment) showed in PBL a dose-effect relationship (r= 0.97; R
2
= 
93.6%; P= 0.007) as well as both CuO rods (r= 0.99; R
2
= 99.3%; P= 0.0002) and INT (r= 0.95; R
2
= 89.9%; P= 
0.05). Only CuO spindles in Raw 264.7 (24h treatment) continue to show a trend (r= 0.95; R
2
= 89.9%; P= 0.05) 
while in PBL (24h treatment) a dose-dependent relationship was found for spheres (r= 0.98; R
2
= 96%; P= 
0.004), spindles (r= 0.93; R
2
= 86.8%; P= 0.02) and rods (r= 0.97; R
2
= 94%; P= 0.007). Statistically significant 
differences from the control were determined by Student’s t-test (**p < 0.01; ***p < 0.001). 
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The 2 and 24h treatments were also used to investigate oxidative DNA damage, by using the 
repair enzymes Endo-III (Figure 10) and Fpg (Figure 11). Both 2 and 24h NP treatments 
demonstrated the induction of Endo III sensitive DNA sites (oxidised pyrimidine) in both cell 
systems. Specifically, after 2h of treatment, Raw 264.7 and PBL showed linear dose-effect 
curves with phagocytic cells particularly susceptible to spindles and rods treatments, while the 
lymphocytes appear to be generally more sensitive to 24h CuO spheres exposures. FPG, 
instead, induced significant increases in strand breaks due to oxidised purines at all 
concentrations tested at 2h for Raw 264.7 and PBL. Moreover, the PBL 24h treatments (CuO 
spheres and rods) showed dose-dependent effects more than Raw 264.7 (CuO spindles). CuO 
spheres treatments were the most effective in macrophages while rods exposures were the 
most effective in lymphocytes. 
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Figure 10. Oxidative Pyrimidines DNA damage after 2h (above) and 24h (bottom) CuO NPs treatment in cell 
cultures. Endo-III sensitive sites in treated, untreated (C-), and positive control (C+: 10 µM H2O2) cultures are 
shown. Statistically significant differences from the control were determined by Student’s t-test (*p < 0.05; **p 
< 0.01; ***p < 0.001). 2h CuO spheres treatment in Raw 264.7 showed a dose-effect relationship (r=0.97; R
2
= 
94%; P= 0.03) as well as CuO INT exposure (r=0.98; R
2
= 96.7%; P= 0.016). In 2h whole blood treatment, a 
dose-effect relationship was found in spheres (r=0.99; R
2
= 98.4%; P= 0.008), rods (r=0.99; R
2
= 98.6%; P= 
0.007) and CuO INT (r=0.98; R
2
= 95.2%; P= 0.02). After 24h, CuO spheres and spindles showed a dose-effect 
relationship in Raw 264.7 (r=0.99; R
2
= 98.8%; P= 0.006 and r=0.96; R
2
= 91.4%; P= 0.04, respectively) and also 
in PBL 24h exposure a dose-effect relationship was found for CuO spheres (r=0.99; R
2
= 98%; P= 0.01), rods 
(r=0.99; R
2
= 99.4%; P= 0.003) and CuO INT (r=0.98; R
2
= 96.6%; P= 0.02). 
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Figure 11. Oxidative Purines DNA damage after 2h (above) and 24h (bottom) CuO NPs treatment in cell 
cultures. Fpg sensitive sites in treated, untreated (C-), and positive control (C+: 10 µM H2O2) cultures are 
shown. Statistically significant differences from the control were determined by the Student’s t-test (***p < 
0.001). 2h CuO spheres treatment in Raw 264.7 showed a dose-effect relationship (r=0.95; R
2
= 91%; P= 0.04) as 
well as spindles (r=0.99; R
2
= 97.4%; P= 0.013), rods (r=0.95; R
2
= 90%; P= 0.04) and CuO INT (r=0.95; R
2
= 
89.7%; P= 0.05) exposure. For 2h whole blood treatments, a dose-effect relationship was found in spheres 
(r=0.98; R
2
= 96%; P= 0.02), rods (r=0.97; R
2
= 93.5%; P= 0.03) and CuO INT (r=0.97; R
2
= 93.5%; P= 0.03). 
After 24h, only CuO spindles showed a dose-effect relationship in Raw 264.7 (r=0.99; R
2
= 97.3%; P= 0.01) 
while in PBL 24h exposures, CuO spheres (r=0.97; R
2
= 94%; P= 0.03) and rods (r=0.99; R
2
= 98.3%; P= 0.009) 
showed a dose-effect relationship. 
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Fluorescence in situ hybridization 
FISH assay was performed with 1 μg\ml of CuO NPs. Performing FISH analysis, a trend of 
MN induction in response to NP exposures comparable to the results obtained performing 
CBMN Cyt assay was found (Table III). All CuO NPs induced an increased number of both 
MN C+ and MN C respect to untreated control, however it is possible to observe that all 
treatments induced a significant increase in aneuploidogenic response (MN C+) in both cell 
systems, with a consistent different behaviour of CuO NPs in Raw 264.7 treatments. In 
macrophagic cells, although the aneuploidogenic events are predominant, CuO INT and 
spindles showed a major degree of clastogenic events (MN C-) respect to spheres and rods. 
 
 
Table III. FISH analysis. Percentage of centromere negative (MN C-) and centromere positive (MN C+) 
micronuclei in binucleated Raw 264.7 and PBL cells (BNMN) incubated with 1 µg\ml of CuO NPs as evaluated 
with the CBMN Cyt assay in combination with fluorescence in situ hybridization. MMC, 0.17 µg\ml mitomycin 
C. Statistically significant differences from the negative control were determined by Student’s t-test and all data 
result p < 0.05 respect to relative control. 
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Gold nanoparticles 
MTT assay 
MTT assay was performed with 0.1, 1, 10 and 100 μg\ml of Au NPs (Fig. 12). 2h Au40 
exposure at lowest and intermediate tested concentrations has led to a reduction in cell 
viability in both cell systems, while Au5 was the most effective at the highest concentration. 
In Raw 264.7 a dose-effect relationship was found after Au5 treatment. After 24h exposure, 
the two cell types showed a slightly different sensitivity to the Au NPs tested, except for the 
highest dose of Au15. Both cell systems showed greater sensitivity after Au15 exposure, 
especially at the highest doses. All the Au NPs tested showed dose-effect relationships, except 
for Au5 in PBL. 
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Figure 12. Effects of Au NPs treatments on the viability of Raw 264.7 and whole blood by MTT assay. Cell 
viability was assessed by MTT assay and results are presented as a percentage of negative control viability. C+: 
10µM H2O2. Cells were treated with the indicated concentrations of Au NPs for 2h (above) and 24h (bottom). 
Statistically significant differences from the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; 
***p < 0.001). Each data represent the mean of two separate experiments and error bars represent the standard 
error of the mean. In Raw 264.7 (2h treatment) Au5 showed a dose-effect relationship (r= -0.89; R
2
= 80.2%; P= 
0.04). (24h treatment) All Au NPs showed a dose-effect relationship in Raw 264.7 (Au5: r= -0.92; R
2
= 84.7%; 
P= 0.026; Au15: r= -0.94; R
2
= 88.8%; P= 0.016; Au40: r= -0.94; R
2
= 89%; P= 0.016) as well as Au15 (r= -0.96; 
R
2
= 91.9%; P= 0.01) and Au40 (r=-0.88; R
2
= 77.9%; P= 0.047) exposures in PBL. 
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CBMN cytome assay 
CBMN cytome assay was performed with 0.1, 1, 10 and 100 μg\ml of Au NPs. Table IV 
summarizes the results of cell proliferation and cytostasis measured by scoring the CBPI and 
mitotic, apoptotic and necrotic indices after Au NPs exposure. All doses in macrophage cell 
system reduce the proliferation index in a statistically significant manner, except for the 
lowest doses of Au40; the 100 µg\ml dose of Au15 was toxic. In lymphocytes, Au5 reduced 
the proliferation in a strong way at all the doses, even if the greater reduction was caused by 
the highest dose of Au15; the proliferation block has been reflected in the mitotic index as 
well as in the apoptotic and in the necrotic indices. In Raw 264.7 the reduction in the mitotic 
index was more evident after Au15 exposure, while Au40 induced an increase in the apoptotic 
cells frequency. The necrotic index was increased after Au5 treatment respect to the other Au 
NPs.  A linear relationship was found for almost all the indices in both cell systems, except 
for the apoptotic index in Raw 264.7. 
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Table IV. CBPI, mitotic, apoptotic and necrotic indices scored by CBMN Cyt assay. Statistically significant 
differences from the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). Each 
data represent the mean of two separate experiments ± the standard error of the mean. Linear regression for 
CBPI in Raw 264.7: Au5 r= -0.89; R
2
= 79.2%; P= 0.043; Au40: r= -0.96; R
2
= 92.7%; P= 0.009. Linear 
regression for CBPI in PBL: Au5 r= -0.92; R
2
= 84.4%; P= 0.028;  Au15: r= -0.93; R
2
= 87%; P= 0.02; Au40: r= -
0.98; R
2
= 96.1%; P= 0.0033. Linear regression for mitotic index in Raw 264.7: Au5: r= -0.91; R
2
= 83%; P= 
0.032; Au40: r= -0.99; R
2
= 97.7%; P= 0.0015. Linear regression for mitotic index in PBL: Au15 r= -0.97; R
2
= 
93.5%; P= 0.0073; Au40 r= -0.90; R
2
= 80.9%; P= 0.038. Linear regression for apoptotic index in PBL: Au15 r= 
0.89; R
2
= 78.5%; P= 0.045. Linear regression for necrotic index in PBL: Au5 r= 0.95; R
2
= 88.7%; P= 0.017; 
Au15 r= 0.91; R
2
= 83.6%; P= 0.03; Au40 r= 0.95; R
2
= 91.2%; P= 0.0011. 
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Figure 13 shows the micronuclei frequency obtained by treating Raw 264.7 cells and blood 
cultures with different mass concentrations of Au NP suspensions. The frequency of 
micronuclei is much higher in phagocytic cells compared to lymphocytes after Au15 
treatment, while it is almost comparable to the other Au NPs. The Au15 induced a greater 
micronuclei formation in both cell systems. The Au5 exposure did not induced MN formation 
in both cell systems at the lowest doses. A linear relationship was found in the MN induction 
by all the treatments except the Au5 exposure  in Raw 264.7. 
 
 
 
Figure 13. Micronuclei frequency determined by CBMN Cyt assay in Raw 264.7 and PBL from whole blood 
after Au NPs exposure at indicated mass concentrations (µg\ml). C+, 0.17 µg\ml 1 mitomycin C. Statistically 
significant differences from the control were determined by Student’s test (*p < 0.05; **p < 0.01; ***p < 0.001). 
Raw 264.7 Au15 treatment showed a dose-effect relationship (r= 0.95; R
2
= 89.5%; P= 0.05) as well as the Au40 
exposure (r= 0.99; R
2
= 98.5%; P= 0.007). PBL Au5 treatment showed a dose-effect relationship (r= 0.998; R
2
= 
99.7%; P= 0.0014) as well as  Au15 (r= 0.996; R
2
= 93.4%; P= 0.034) and Au40 (r= 0.97; R
2
= 93.6%; P= 0.03) 
exposures. 
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The induction of nucleoplasmic bridges formation (Fig. 14) was greater both in Raw 264.7 
cells and in PBL after Au15exposure. Phagocytic cells did not show any significant increase 
in NPB frequency after Au5 exposure but a greater sensitivity to highest treatment with Au40 
respect to lymphocytes. Moreover, in Raw 264.7 Au40 showed a significant dose-dependent 
increase in NPB frequency as well as Au5 and Au15 in PBL cultures. 
 
 
 
Figure 14. Nucleoplasmic bridges frequency determined by CBMN Cyt assay after Au NPs exposure at 
indicated mass concentrations (µg\ml). C+, 0.17 µg\ml mitomycin C. Statistically significant differences from 
the control were determined by Student’s t-test (**p < 0.01; ***p < 0.001). Raw 264.7 Au40 treatment showed a 
dose-effect relationship (r= 0.97; R
2
= 94.3%; P= 0.0058). PBL Au5 treatment showed a dose-effect relationship 
(r= 0.95; R
2
= 90.8%; P= 0.012) as well as Au15 (r= 0.97; R
2
= 93.5%; P= 0.033) exposure. 
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Nuclear buds (NBUD) were significantly generated in Raw 264.7 after exposure to Au15 and 
Au40, with the first the most effective; Au5 did not exert any significant induction in NBUD 
formation (Figure 15).  In lymphocytes, only the lowest dose of Au5 did not induce any 
significant effect; Au15 induced the most effective increase of nuclear bud frequency. A dose-
effect relationship was found in Raw 264.7 after Au40 treatment and in PBL after Au5 and 
Au15 exposures. 
 
 
Figure 15. Nuclear buds frequency determined by CBMN Cyt assay after Au NPs exposure at indicated mass 
concentrations (µg\ml). C+, 0.17 µg\ml mitomycin C. Statistically significant differences from the control were 
determined by Student’s t-test (**p < 0.01; ***p < 0.001). Raw 264.7 Au40 treatment showed a dose-effect 
relationship (r= 0.95; R
2
= 89.5%; P= 0.015). PBL Au5 treatment showed a dose-effect relationship (r= 0.87; R
2
= 
77.1%; P= 0.05) as well as Au15 (r= 0.93; R
2
= 87%; P= 0.02) exposure. 
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Primary and oxidative DNA damage 
Comet assay was performed with 0.1, 1, 10 and 100 μg\ml of Au NPs, while the version 
modified by using the restriction enzymes was performed with 0.1, 1 and 10μg\ml of Au NPs. 
Figure 16 shows data obtained in evaluating the Au NP-induced DNA damage by the comet 
assay. Increase in DNA migration (i.e., primary DNA damage) was significantly detected 
after 2 and 24h treatments. Comparing the two cell systems, it is evident that lymphocytes 
were most sensitive in many cases both after 2 and 24h. Significant trends were found in Raw 
264.7 for all the AuNPs tested (2 and 24h) and in PBL except for the Au5 treatment. In Raw 
264.7 Au15 were the most effective in inducing DNA fragmentation after 2h while after 24h 
there was no relevant difference among the treatments. In PBL Au5 were the most effective 
after 2h exposure and at the lowest doses after 24h, with Au15 the most effective at the 
highest doses. 
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Figure 16. Primary DNA damage. Comet assay revealed an increase in primary DNA damage, with different 
sensitivity shown by cell types at 2h (above) and 24 h (bottom) treatment. C+: 10 µM H2O2. (2h treatment) Au5 
treatment in Raw 264.7 showed a dose-effect relationship (r= 0.99; R
2
= 97.8%; P= 0.0041) as well as Au15 (r= 
0.92; R
2
= 85.2%; P= 0.025) and Au40 (r= 0.97; R
2
= 95.2%; P= 0.0045) exposures. Au5 showed in PBL a dose-
effect relationship (r= 0.88; R
2
= 76.9%; P= 0.05) as well as Au15 (r= 0.98; R
2
= 97.2%; P= 0.002) and Au40 (r= 
0.95; R
2
= 91.1%; P= 0.012). (24h treatment) In Raw 264.7 all Au NPs tested showed a dose-effect relationship 
(Au5: r= 0.99; R
2
= 87.6%; P= 0.0016; Au15: r= 0.98; R
2
= 85.3%; P= 0.0044; Au40: r= 0.98; R
2
= 96.7%; P= 
0.0026 ). In PBL a dose-dependent relationship was found for Au15 (r= 0.97; R
2
= 94.4%; P= 0.0057) and Au40 
(r= 0.86; R
2
= 74.1%; P= 0.05). Statistically significant differences from the control were determined by 
Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). 
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The two treatments (2 and 24h ) were also used to investigate oxidative DNA damage, by 
using the repair enzymes Endo-III (Figure 17) and Fpg (Figure 18). Both 2 and 24h NP 
treatments demonstrated the induction of Endo III sensitive DNA sites (oxidised pyrimidine) 
in Raw 264.7; in PBL the induction was demonstrated after 24h for all the Au NPs but only 
for Au5 after 2h. Specifically, after 2h of treatment, Raw 264.7 showed linear dose-effect 
curves after Au15 and Au40 exposure and a high sensitivity for all the treatment, while the 
lymphocytes appear to be more sensitive to Au5 exposures. After 24h, all the treatments 
induced a great increase in pyrimidine oxidation, with macrophages more sensitive. FPG 
induced significant increases in strand breaks due to oxidised purines at all concentrations 
tested at 2h and 24h for Raw 264.7, while PBL seemed to be more sensitive at 2h.  
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Figure 17. Oxidative Pyrimidines DNA damage after 2h (above) and 24h (bottom) Au NPs treatment in cell 
cultures. Endo-III sensitive sites in treated, untreated (C-), and positive control (C+: 10 µM H2O2) cultures are 
shown. Statistically significant differences from the control were determined by Student’s t-test (*p < 0.05; **p 
< 0.01; ***p < 0.001). (2h treatment) In Raw 264.7 Au15 showed a dose-effect relationship (r=0.96; R
2
= 93.1%; 
P= 0.035) as well as Au40 exposure (r=0.96; R
2
= 93%; P= 0.036). In whole blood treatment, a dose-effect 
relationship was found in Au40 (r=0.97; R
2
= 95.2%; P= 0.024). (24h treatment) In Raw 264.7Au5 and Au15 
showed a dose-effect relationship (r=0.99; R
2
= 98.2%; P= 0.009 and r=0.99; R
2
= 98.8%; P= 0.006, respectively) 
and also in PBL (r=0.94; R
2
= 89%; P= 0.05 and r=0.97; R
2
= 94.4%; P= 0.03 ). 
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Figure 18. Oxidative Purines DNA damage after 2h (above) and 24h (bottom) Au NPs treatment in cell cultures. 
Fpg sensitive sites in treated, untreated (C-), and positive control (C+: 10 µM H2O2) cultures are shown. 
Statistically significant differences from the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; 
***p < 0.001). (2h treatment) In Raw 264.7 Au15 showed a dose-effect relationship (r=0.99; R
2
= 97.4%; P= 
0.01) as well as Au40 exposure (r=0.99; R
2
= 99%; P= 0.005). In whole blood treatment, a dose-effect 
relationship was found in Au5 and Au15 (r=0.99; R
2
= 98.2%; P= 0.0086 and r=0.99; R
2
= 98.6%; P= 0.0072, 
respectively). (24h treatment) In Raw 264.7Au5 and Au40 showed a dose-effect relationship (r=0.98; R
2
= 97%; 
P= 0.015 and r=0.99; R
2
= 98.2%; P= 0.009, respectively) while in PBL only Au15 showed a dose-effect 
relationship  (r=0.99; R
2
= 97.1%; P= 0.014). 
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Fluorescence in situ hybridization 
MTT assay was performed with 0.1, 1 and 10 μg\ml of Au NPs .Performing FISH analysis, a 
trend of MN induction in response to NP exposures comparable to the results obtained 
performing CBMN Cyt assay was found (Figure 19). It is possible to observe that all 
treatments induced a significant increase in aneuploidogenic response (MN C+) in both cell 
systems, except the lowest dose of Au5 and Au40, with a consistent different behaviour of 
Au15 in Raw 264.7 treatments. In PBL, Au15 were the most effective at the lowest dose in 
inducing aneuploidogenic events, while at the highest doses the responses of all Au NPs were  
comparable. 
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Figure 19. FISH analysis. Percentage of centromere negative (MN C-) and centromere positive (MN C+) 
micronuclei in binucleated Raw 264.7 (above) and in binucleated PBL (bottom) incubated with Au NPs as 
evaluated with the CBMN Cyt assay in combination with fluorescence in situ hybridization. C+, 0.17 µg\ml 
mitomycin C. Statistically significant differences from the control were determined by Student’s t-test (*p < 
0.05; **p < 0.01; ***p < 0.001). 
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Silver nanoparticles 
 
MTT assay 
MTT assay was performed with 0.001, 0.01, 0.1 and 1 μg\ml of Ag NPs (Fig. 25) in Raw 
264.7. 2h Ag20 and Ag10-PVP exposures have led to an evident reduction in cell viability, 
while Ag40 and Ag95 did not cause any decrease in viability. After 24h exposure, all the Ag 
NPs tested induced a decrease in cell viability, with Ag10-PVP the most effective. Phagocytic 
cells showed a dose-dependent cytotoxicity trend both in Ag95 and Ag10-PVP exposure, 
while none of the treatments showed a statistically significant correlation after 24h exposure.  
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Figure 25. Effects of Ag NPs treatments on the viability of Raw 264.7 by MTT assay. Cell viability was 
assessed by MTT assay and results are presented as a percentage of negative control viability. C+: 10µM H2O2. 
Cells were treated with the indicated concentrations of Ag NPs for 2h and 24h. Statistically significant 
differences from the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). Each 
data represent the mean of two separate experiments and error bars represent the standard error of the mean. 2h 
Ag95 treatment showed a dose-effect relationship (r= -0.96; R
2
= 91.9%; P= 0.01) as well as Ag10-PVP exposure 
(r= -0.94; R
2
= 88%; P= 0.018). None of 24h treatments showed dose-effect correlations. 
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Trypan blue dye exclusion 
Trypan blue dye exclusion was performed with 0.001, 0.01, 0.1 and 1 μg\ml of Ag NPs (Fig. 
26) in Raw 264.7. 2h Ag NPs exposure caused a reduction in cell viability except for Ag10-
PVP: the decrease was more evident for nanomaterials with smaller dimensions (Ag20). After 
24h exposure, the Ag NPs caused an increase in cell mortality, especially at the highest doses, 
with the following rank: Ag20>Ag40>Ag95>Ag10-PVP. All the CuO NPs showed a dose-
dependent cytotoxicity trend after 24h, while after 2h only Ag40 and Ag95 showed the dose-
dependent correlation. 
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Figure 26. Effects of Ag NPs treatments on the viability of Raw 264.7 by Trypan blue dye exclusion. Results are 
presented as a percentage of negative control viability. C+: 10µM H2O2. Cells were treated with the indicated 
concentrations of Ag NPs for 2h and 24h. Statistically significant differences from the control were determined 
by Student’s t-test (*p < 0.05; **p < 0.01). Each data represent the mean of two separate experiments and error 
bars represent the standard error of the mean. 2h Ag40 and Ag95 treatments showed a dose-effect relationship 
(r= -0.94; R
2
= 88.6%; P= 0.017 and  r= -0.98; R
2
= 96.7%; P= 0.0026, respectively ). All 24h treatments showed 
dose-effect relationships  (Ag20: r= -0.95; R
2
= 90.3%; P= 0.013; Ag40: r= -0.89; R
2
= 79.6%; P= 0.042; Ag95: 
r= -0.98; R
2
= 97.3%; P= 0.002; Ag10-PVP: r= -0.97; R
2
= 94.3%; P= 0.006).  
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CBMN cytome assay 
CBMN cytome assay was performed with 0.001, 0.01, 0.1 and 1μg\ml of Ag NPs. Table V 
summarizes the results of cell proliferation and cytostasis measured by scoring the CBPI and 
mitotic, apoptotic and necrotic indices after Ag NPs exposure. All doses of Ag20, Ag40 and 
Ag10-PVP in macrophage cell system reduce the proliferation index in a statistically 
significant manner, except for the lowest doses of Ag40; Ag95 had a fickle behaviour. The 
reduction of the mitotic index was evident after all the Ag NPs exposures, except the Ag20 
lowest dose, while the apoptotic and the necrotic indices were increased sporadically. A linear 
relationship was found only in the apoptotic index after Ag20 and Ag10-PVP exposures. 
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Table V. CBPI, mitotic, apoptotic and necrotic indices scored by CBMN Cyt assay. C+, 0.17 µg\ml mitomycin 
C. Statistically significant differences from the control were determined by Student’s t-test (*p < 0.05; **p < 
0.01; ***p < 0.001). Each data represent the mean of two separate experiments ± the standard error of the mean. 
Linear regression for apoptotic index: Ag20 r= 0.96; R
2
= 91.7%; P= 0.01; Ag10-PVP: r= 0.96; R
2
= 92%; P= 
0.009. 
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Figure 27 shows the micronuclei frequency obtained by treating Raw 264.7 cells and blood 
cultures with different mass concentrations of Ag NP suspensions. At the highest dose, the 
frequency of micronuclei is higher after Ag40 treatment, while it is almost comparable for the 
other Ag NPs. At the lowest doses only Ag95 treatment increased the MN frequency in a 
statistically significant manner. A linear relationship was found in the MN induction by all the 
treatments except the Ag95 exposure. 
 
 
 
Figure 27. Micronuclei frequency determined by CBMN Cyt assay in Raw 264.7 after Ag NPs exposure at 
indicated mass concentrations (µg\ml). C+, 0.17 µg\ml mitomycin C. Statistically significant differences from 
the control were determined by Student’s test (*p < 0.05; **p < 0.01; ***p < 0.001). Ag20 treatment showed a 
dose-effect relationship (r= 0.92; R
2
= 84.3%;  P= 0.028) as well as Ag40 (r= 0.93; R
2
= 87%; P= 0.021) and 
Ag10-PVP (r= 0.89; R
2
=79.1%; P= 0.0435) exposures. 
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The induction of nucleoplasmic bridges formation (Fig. 28) was great in Raw 264.7 cells after 
all Ag NPs exposure, except for Ag10-PVP. A greater sensitivity to highest treatments with 
Ag20 and Ag95 was found, while at the lowest dose only Ag20 was effective. All the Ag NPs 
exposures showed a significant dose-dependent increase in NPB frequency. 
 
 
 
Figure 28. Nucleoplasmic bridges frequency determined by CBMN Cyt assay after Ag NPs exposure at 
indicated mass concentrations (µg\ml). C+, 0.17 µg\ml mitomycin C. Statistically significant differences from 
the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). All treatment showed 
dose-effect relationships (Ag20: r= 0.93; R
2
= 87.1%;  P= 0.02; Ag40: r= 0.89; R
2
= 79.2%;  P= 0.043; Ag95: r= 
0.90; R
2
= 81.8%;  P= 0.035; Ag10-PVP: r= 0.95; R
2
= 90.7%;  P= 0.012). 
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Nuclear buds (NBUD) were significantly generated in Raw 264.7 after exposure to Ag20, 
showing a dose-response correlation. Ag40 and Ag95 induced a statistically significant 
increase of NBUD frequency only at the highest dose although they showed a dose-dependent 
correlation, while Ag10-PVP did not increase the number of nuclear buds at any of the tested 
concentrations (Figure 29). 
 
 
Figure 29. Nuclear buds frequency determined by CBMN Cyt assay after Ag NPs exposure at indicated mass 
concentrations (µg\ml). C+, 0.17 µg\ml mitomycin C. Statistically significant differences from the control were 
determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). Ag20 treatment showed a dose-effect 
relationship (r= 0.93; R
2
= 86.1%;  P= 0.023) as well as Ag40 (r= 0.96; R
2
= 92.1%;  P= 0.01) and Ag95 (r= 0.91; 
R
2
= 82.1%;  P= 0.034). 
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Primary and oxidative DNA damage 
Comet assay was performed with 0.001, 0.01, 0.1 and 1 μg\ml of Ag NPs, while the version 
modified by using the enzymes was performed with 0.01, 0.1 and 1 μg\ml of Ag40 and Ag10-
PVP, in order to test if the presence or the absence of capping can induce a modification in the 
oxidative status of DNA. Figure 30 shows data obtained in evaluating the Ag NP-induced 
DNA damage by the comet assay. Increase in DNA migration (i.e., primary DNA damage) 
was significantly detected after 2 and 24h treatments. Ag40 was the most effective both after 
2 and 24h, with a significant trend for both exposure times. Significant trends were also found 
for Ag20 (2h) and for Ag95 (24h). Ag10-PVP was the less effective in inducing DNA 
damage, with a percentage of DNA in tail which did not change increasing the mass 
concentration or the time of exposure.  
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Figure 30. Primary DNA damage. Comet assay revealed an increase in primary DNA damage at 2h (above) and 
24h (bottom) treatments. C+: 10 µM H2O2. Statistically significant differences from the control were determined 
by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). 2h Ag20 treatment showed a dose-effect relationship 
(r= 0.94; R
2
= 88.4%;  P= 0.02) as well as 2h Ag40 exposure (r= 0.92; R
2
= 85.5%;  P= 0.025). 24h Ag40 
treatment showed a dose-effect relationship (r= 0.97; R
2
= 93.4%;  P= 0.007) as well as 24h Ag95 exposure (r= 
0.90; R
2
= 80.8%;  P= 0.038). 
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The two treatments (2 and 24h ) were also used to investigate oxidative DNA damage, by 
using the repair enzymes Endo-III (Figure 31) and Fpg (Figure 32). Both 2 and 24h NP 
treatments demonstrated the induction of Endo III sensitive DNA sites (oxidised pyrimidine) 
in Raw 264.7, except for the lowest doses of Ag10-PVP after 2h. Specifically, after 2h of 
treatment, Raw 264.7 showed linear dose-effect curves after Ag40 exposure and a high 
sensitivity for all the treatment, while the Ag10-PVP appear to be more effective after 24h, 
nevertheless the damage caused by the treatments was always less than Ag40 damage 
induction. FPG induced significant increases in strand breaks due to oxidised purines at all 
concentrations tested at 2h and 24h, with the Ag40 the most effective. A dose-effect 
relationship was found after 2h Ag40 treatment and after Ag10-PVP exposure.   
 
 
 
Figure 31. Oxidative Pyrimidines DNA damage after 2h and 24h Ag NPs treatment in cell cultures. Endo-III 
sensitive sites in treated, untreated (C-), and positive control (C+: 10 µM H2O2) cultures are shown. Statistically 
significant differences from the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 
0.001). Ag40 treatment showed a dose-effect relationship both after 2h (r=0.97; R
2
= 93.6%; P= 0.032) and after 
24h (r=0.98; R
2
= 99.5%; P= 0.002). 
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Figure 32. Oxidative Purines DNA damage after 2h and 24h Ag NPs treatment in cell cultures. Fpg sensitive 
sites in treated, untreated (C-), and positive control (C+: 10 µM H2O2) cultures are shown. Statistically 
significant differences from the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 
0.001). 2h Ag40 treatment showed a dose-effect relationship (r=0.99; R
2
= 97.4%; P= 0.013) as well as 24h 
Ag10-PVP exposure (r=0.95; R
2
= 90.8%; P= 0.047). 
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Silica  nanoparticles 
 
MTT assay 
MTT assay was performed with 0.1, 1, 10 and 100 μg\ml of SiO2 NPs (Fig. 33) in Raw 264.7. 
2h treatment have led to an evident  reduction in cell viability only at the highest doses of 
SiO2-50AM exposure, while after 24h exposure, also the SiO2-25 treatment induced a 
decrease in cell viability.. Only 2h SiO2-50AM treatment showed a dose-effect relationship.  
 
 
Figure 33. Effects of SiO2 NPs treatments on the viability of Raw 264.7 by MTT assay. Cell viability was 
assessed by MTT assay and results are presented as a percentage of negative control viability. C+: 10µM H2O2. 
Cells were treated with the indicated concentrations of SiO2 NPs for 2h and 24h. Statistically significant 
differences from the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). Each 
data represent the mean of two separate experiments and error bars represent the standard error of the mean. 
Only 2h SiO2-50AM treatment showed a dose-effect relationship (r= -0.93; R
2
= 87%; P= 0.021). 
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Trypan blue dye exclusion 
Trypan blue dye exclusion was performed with 0.1, 1, 10 and 100 μg\ml of SiO2 NPs (Fig. 
34) in Raw 264.7. Contrary to the results obtained with the MTT assay, SiO2-50AM did not 
caused a reduction in cell viability at any time exposure. After 2h, none of the treatments 
caused decrease of cell viability. SiO2-25 and SiO2-50 showed a decrease in the number of 
viable cells after 24h, with SiO2-25 the most effective. None of the SiO2 treatments showed 
the dose-dependent correlation. 
 
 
Figure 34. Effects of SiO2 NPs treatments on the viability of Raw 264.7 and whole blood by Trypan blue dye 
exclusion. Results are presented as a percentage of negative control viability. C+: 10µM H2O2. Cells were 
treated with the indicated concentrations of SiO2 NPs for 2h and 24h. Statistically significant differences from 
the control were determined by Student’s t-test (*p < 0.05; **p < 0.01). Each data represent the mean of two 
separate experiments and error bars represent the standard error of the mean. None of the treatments showed a 
dose-effect relationship.  
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CBMN cytome assay 
CBMN cytome assay was performed with 0.1, 1, 10 and 100 μg\ml of SiO2 NPs in Raw 
264.7. Table VI summarizes the results of cell proliferation and cytostasis measured by 
scoring the CBPI and mitotic, apoptotic and necrotic indices after SiO2 NPs exposure. All 
SiO2 NPs reduced the proliferation index in a statistically significant manner, with the SiO2-
50AM the most effective at the lowest doses and SiO2-50 at the highest dose; all the SiO2 NPs 
showed a dose-effect response. The reduction of the mitotic index was evident after all the 
SiO2 NPs exposures, except the 1 μg\ml dose of SiO2-25. SiO2-25 and SiO2-50 increased the 
apoptotic figures in a dose-dependent manner as well as the necrotic index, while SiO2-50AM 
was, at the highest dose, the less effective in the activation of apoptotic and necrotic 
pathways. 
 
Table VI. CBPI, mitotic, apoptotic and necrotic indices scored by CBMN Cyt assay. C+, 0.17 µg\ml mitomycin 
C. Statistically significant differences from the control were determined by Student’s t-test (*p < 0.05; **p < 
0.01; ***p < 0.001). Each data represent the mean of two separate experiments ± the standard error of the mean. 
Linear regression for CBPI: SiO2-25 r= -0.99; R
2
= 97.7%; P= 0.0015; SiO2-50: r= -0.93; R
2
= 87%; P= 0.021; 
SiO2-50AM r= -0.94; R
2
= 88.2%; P= 0.018. Linear regression for apoptotic index: SiO2-25 r=  0.96; R
2
= 92.5%; 
P= 0.009; SiO2-50 r= 0.89; R
2
= 79.7%; P= 0.04. Linear regression for necrotic index: SiO2-25 r= 0.93; R
2
= 
85.7%; P= 0.024; SiO2-50 r= 0.94; R
2
= 87.7%; P= 0.02.  
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Figure 35 shows the micronuclei frequency obtained by treating Raw 264.7 cells with 
different mass concentrations of SiO2 NPs suspensions. Although all the SiO2 NPs increased 
the MN frequency, SiO2-50AM was the most effective, especially at the highest dose. A linear 
relationship was found after all the SiO2 treatments. 
 
 
 
Figure 35. Micronuclei frequency determined by CBMN Cyt assay in Raw 264.7 after SiO2 NPs exposure at 
indicated mass concentrations (µg\ml). C+, 0.17 µg\ml mitomycin C. Statistically significant differences from 
the control were determined by Student’s test (*p < 0.05; **p < 0.01; ***p < 0.001). SiO2-25 treatment showed a 
dose-effect relationship (r= 0.96; R
2
= 91.8%;  P= 0.01) as well as SiO2-50 (r= 0.95; R
2
= 90.7%; P= 0.0125) and 
SiO2-50AM (r= 0.94; R
2
= 87.7%; P= 0.019) exposure. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
89 
 
The induction of nucleoplasmic bridges formation is shown in Figure 36. SiO2-25 caused an 
increase of NPB at all the doses, except for the lowest one, in a dose-dependent way. The 
greatest sensitivity was found after the treatment with 10 µg\ml of SiO2-50AM, but the 
response has not been observed at the highest dose. SiO2-25 induced an increase in the 
number of nucleoplasmic bridges only at the intermediate dose. 
 
 
Figure 36. Nucleoplasmic bridges frequency determined by CBMN Cyt assay after SiO2 NPs exposure at 
indicated mass concentrations (µg\ml). C+, 0.17 µg\ml mitomycin C. Statistically significant differences from 
the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). SiO2-25 treatment showed 
a dose-effect relationship (r= 0.94; R
2
= 89.1%;  P= 0.016). 
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Nuclear buds (NBUD) were significantly generated in Raw 264.7 after exposure to SiO2 NPs, 
showing a dose-response correlation after SiO2-25 treatment. The tendency of the NBUD 
induction was quite fluctuating, with the SiO2-50AM the most effective at the 1 µg\ml dose 
and SiO2-25 and SiO2-50 at the highest dose (Figure 37). 
 
 
Figure 37. Nuclear buds frequency determined by CBMN Cyt assay after SiO2 NPs exposure at indicated mass 
concentrations (µg\ml). C+, 0.17 µg\ml mitomycin C. Statistically significant differences from the control were 
determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 0.001). SiO2-25 treatment showed a dose-effect 
relationship (r= 0.95; R
2
= 89.3%;  P= 0.015). 
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Primary and oxidative DNA damage 
Comet assay was performed with 0.1, 1, 10 and 100 μg\ml of SiO2 NPs, while the version 
modified by using the restriction enzymes was performed with 0.1, 1 and 10 μg\ml of SiO2-50 
and SiO2-50AM, in order to test if the presence of the amino group can induce a modification 
in the oxidative status of DNA. Figure 38 shows data obtained in evaluating the SiO2 NP-
induced DNA damage by the comet assay. Increase in DNA migration (i.e., primary DNA 
damage) was significantly detected after 2, with a dose-dependent correlation after SiO2-25 
exposure; after 24h only the SiO2-50AM treatment induced a statistically significant increase 
in the DNA damage in a dose-dependent way.  SiO2-50 was the less effective, especially after 
24h treatment.  
 
 
Figure 38. Primary DNA damage. Comet assay revealed an increase in primary DNA damage at 2h and 24 h 
treatment. C+: 10 µM H2O2. Statistically significant differences from the control were determined by Student’s t-
test (*p < 0.05; **p < 0.01; *** p< 0.001). 2h SiO2-50 treatment showed a dose-effect relationship (r= 0.93; R
2
= 
86.6%; P= 0.022) as well as 24h SiO2-50AM exposure (r= 0.98; R
2
= 96%;  P= 0.0034). 
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The 2 and 24h treatments were also used to investigate oxidative DNA damage, by using the 
repair enzymes Endo-III (Figure 39) and Fpg (Figure 40). Both 2 and 24h NP treatments 
demonstrated the induction of Endo III sensitive DNA sites (oxidised pyrimidine) in Raw 
264.7. Specifically, after 2h of treatment, macrophage cells system showed an increase in 
oxidised pyrimidines with an higher sensitivity for the SiO2-50AM  treatment. The detection 
of oxidised purines was statistically significant only after 24h of treatment, nevertheless there 
was an increase in FPG-sensitive sites at the highest dose of SiO2-50. SiO2-50AM  was the 
most effective at the lowest and the highest doses, while SiO2-50 at the intermediate dose. A 
dose-effect relationship was not found after SiO2 NPs exposures.   
 
 
Figure 39. Oxidative pyrimidines DNA damage after 2h and 24h SiO2 NPs treatment in cell cultures. Endo-III 
sensitive sites in treated, untreated (C-), and positive control (C+: 10 µM H2O2) cultures are shown. Statistically 
significant differences from the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 
0.001). 24h  SiO2-50AM treatment showed a dose-effect relationship (r= 0.97; R
2
= 95.3%; P= 0.024).  
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Figure 40. Oxidative Purines DNA damage after 2h and 24h SiO2 NPs treatment in cell cultures. Fpg sensitive 
sites in treated, untreated (C-), and positive control (C+: 10 µM H2O2) cultures are shown. Statistically 
significant differences from the control were determined by Student’s t-test (*p < 0.05; **p < 0.01; ***p < 
0.001). None of the treatments showed a dose-effect relationship. 
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DISCUSSION 
This PhD thesis is part of the European FP7 project “NanoReTox - The Reactivity and 
Toxicity of Engineered Nanoparticles: Risks to the Environment and Human Health”. 
NanoReTox intends to examine the molecular and cellular reactivity of well characterised 
nanoparticles on a panel of mammalian and human cell lines. The aim is to discover which 
features of nanoparticles confer reactivity with which cell types/target organs. 
In my work, I focussed on cytotoxic and genotoxic responses following in vitro exposure to a 
set of NPs (CuO, SiO2, Au and Ag NPs) assessed in murine alveolar macrophage cell line 
Raw 264.7 and in freshly isolated human peripheral blood lymphocytes (PBL). Since PBL are 
present in the circulatory system, primary cultures of human PBL are representative of a 
major pathway of NPs distribution in the whole organism. Raw 264.7 cells are considered a 
representative model for the study of lung responses (inflammatory processes) to inhaled 
nanoparticles and ultrafine particles. 
   
CuO nanoparticles 
MTT assay revealed a decrease of cell viability in Raw 264.7 cells and PBL with significant 
dose-effect relationships over the tested concentrations and with distinctive patterns for 
different CuO NP: CuO spheres turned to be the most effective after 2h treatment followed by 
CuO spindles. After 24h exposure, CuO spheres and CuO rods showed the same degree of 
toxicity. Raw 264.7 were slightly more sensitive than PBL, probably because of the 
phagocytic ability of murine macrophages. 
The comparison between cytotoxicity and physicochemical characteristics of CuO NP showed 
a differentiated bio-reactivity however not directly imputable to any of the individual NP 
characteristics. In terms of links with physicochemical properties, there seems to be a better 
correlation between NP available surface area and cytotoxicity as would be expected due to 
the lower surface area of the CuO spindles (Di Bucchianico et al., 2013). However, this 
correlation cannot be applied for the results obtained with the Trypan blue assay. In fact, the 
results indicated a more pronounced decrease of cell viability than those obtained by MTT 
assay. The difference in sensibility of the two tests could be explained by the unsuitability of  
these two tests in the valuation of cell viability after NPs treatments: although extensively 
used in nanotoxicology, MTT assay still requires accurate validation for NPs testing since 
nanoparticles were found to interfere with the optical measurement at concentrations of 50 
μg/cm2 when MTT assays was performed (Kroll et al., 2012); moreover, many conditions can 
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interfere with the assay (presence of albumin or antioxidant agents) leading to false results 
(Monteiro-Riviere et al., 2009; Lewinski et al., 2008; Funk et al., 2007; Bruggiser et al., 
2001). Nevertheless, also Trypan blue has many limitations: the cell viability might have been 
compromised even though the membrane integrity is maintained. 
However, in my work the MTT assay has been modified to better reflect the real effect of NPs 
exposure, thus the data obtained can be more reliable. The results I obtained are consistent 
with those of Karlsson and co-workers: they showed that the viability of the pulmonary 
human-derived A549 cell line, determined after 18h of exposure to 42 nm CuO NPs at 40 
μg/ml and 80 μg/ml doses, was reduced by 90% and 96%, respectively (Karlsson et al., 2008). 
Another study showed toxicity in A549 12h after 0.3 µg/ml CuO NPs (< 50 nm) treatment, 
with a highly significant decrease of cell viability (25%) after exposure to 30 µg NPs/ml: the 
mechanism of action suggested by authors is that the CuO NPs can induce autophagy in A549 
(Sun et al., 2012). 
Cytostatic responses, evaluated by scoring apoptotic, necrotic and mitotic figures as well as 
the proliferation index in CBMN Cyt assay, showed how all the CuO NPs tested caused a 
decrease in the CBPI, accompanied often with a reduction in mitotic index, especially in Raw 
264.7 cells. The activation of programmed cell death was greater than necrosis, especially in 
PBL. The apoptosis has already been suggested as a possible action mechanism of CuO NPs: 
in cultured epithelial cell line from Xenopus laevis (A6) CuO NPs (6 nm diameter) showed 
cell cycle arrest, decrease in cell proliferation and caused significant increase in cell death via 
apoptosis (Thit et al., 2012). In addition, if from the particles Cu
2+
 release occurs, the ions can 
be able to induce apoptosis by directly altering the expression of apoptotic genes as already 
observed in neuronal cells (Chan et al., 2008).    
CuO NP also induced a significant increase in MN frequency in PBL and in Raw 264.7, with 
the macrophage cells generally more sensitive: a possible explanation is the phagocytic ability 
of these cells compared to the lymphocytes. An increase in MN frequency was also observed 
in female rats reticulocytes after 3 mg CuO NPs treatment (Song et al., 2012).  
FISH analysis revealed that all CuO NP I have investigated are able to induce a significant 
increase in missegregation events. This results are in agreement with previous studies where 
multi-walled carbon nanotubes, amorphous SiO2, TiO2 and CoCr were shown inducing 
aneuploidy by mechanical interference with cytoskeleton, causing chromosome 
missegregation (Gonzalez et al., 2010). Overall, results presented in my study provide the 
first evidence of the CuO NPs potential to induce clastogenic as well as aneuploidogenic 
events.  
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The comet assay also showed an increase in primary DNA damage after 2 and 24h treatments: 
CuO INT exposures were the most effective in inducing DNA fragmentation after 2h 
exposure both in Raw 264.7 and PBL (about 4.5-fold and 6-fold higher than in untreated 
control, respectively), while CuO INT and rods were the most effective after 24h exposure. 
Oxidative DNA damage was observed with NP shape-related trends: CuO spheres were the 
most effective in macrophages while rods were the most effective in lymphocytes. 
DNA oxidative lesions have been observed also in A549 cells upon exposure to CuO NPs 
(Karlsson et al., 2008). The findings I obtained are consistent with a wide range of data 
available in the literature, and demonstrate that all CuO NPs studied in my work, 
independently from their size and shape, clearly cause DNA damage. The key mechanism 
proposed to explain the ability of the CuO NPs to cause cell death, DNA damage and 
oxidative DNA lesions could be the effect of CuO NPs on mitochondria, as proposed by 
Wang and co-authors: by using MTT assay, reactive oxygen species (ROS) assay and flow 
cytometric assay, they observed significant toxicity in HepG2 cells and catfish primary 
hepatocytes, with HepG2 cells more sensitive (Wang et al., 2011). The oxidative stress caused 
by mitochondria dysfunction has been proposed as a common mechanism of cell damage 
induced by many types of nanoparticles (Stone et al., 2007). For instance, Fahmy and 
Cormier hypothesized that the cytotoxicity induced by CuO exposure in HepG2 was mediated 
by the generation of oxidative stress. Indeed, co-treatment with the antioxidant resveratrol 
mitigated the cytotoxic effect of CuO, suggesting that oxidative stress was responsible, at 
least in part, for the decreased viability (Fahmy and Cormier, 2009). CuO NPs were found to 
induce oxidative stress in a dose-dependent manner also in human A549 cells, as indicated by 
depletion of glutathione and induction of lipid peroxidation, catalase and superoxide 
dismutase (Ahamed et al., 2010). Recently, Akhtar and co-workers observed that in Balb/3T3 
co-treatment with the antioxidant molecules sulphoraphane and N-acetyl-cysteine 
significantly attenuated glutathione depletion caused by CuO NPs (Akhtar et al., 2011). 
The NP toxicity can be influenced by physicochemical parameters, such as dimension and 
shape: in my study the cytotoxic effects induced by rod-shaped CuO NPs were not dissimilar 
from those induced by spheres, which showed themselves to be more effective only in the 
reduction of CBPI index. Analysing this latter endpoint, PBL turned out to be more sensitive 
than murine macrophages to all CuO spheres treatment, but in case of CuO rods only to the 
highest dose. Nevertheless, rod-shaped CuO NPs showed a greater ability to induce DNA 
strand breaks than spherical CuO NPs after 24h treatment. Piret and co-authors analysed the 
potential toxic effects of two types of copper oxide nanoparticles with different specific 
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surface areas, different shapes (rod or spheric), different sizes as raw materials and similar 
hydrodynamic diameter in suspension on human hepatocarcinoma HepG2 cells. Cytotoxicity, 
inflammatory and antioxidative responses and activation of intracellular transduction 
pathways induced by rod-shaped CuO NPs were more severe than spherical CuO NPs, and 
the obtained transcriptomic data, siRNA knockdown and DNA binding activities suggested 
that Nrf2, NF-κB and AP-1 were involved in the response of HepG2 cells to CuO NPs (Piret 
et al., 2012). CuO NP incubation also induced activation, in HepG2, of MAPK pathways, 
ERKs and JNK/SAPK, playing a major role in the activation of AP-1 (Piret et al., 2012). 
Prabhu and co-workers have determined the effects of CuO NPs of different dimensions (40-
60-80 nm) and at different concentrations (10-100 mM) for 24 hours on neurons that 
innervate the skin. The results obtained showed a strong cellular vacuolation and detachment 
of some neurons from the substrate. A further analysis of the results showed that the 40 nm 
CuO NPs, at the highest concentration tested, induced the highest toxicity (Prabhu et al., 
2010). 
NP cytotoxicity also depends on intracellular solubility as demonstrated by a comparison of 
carbon-stabilized copper metal NPs and degradable CuO NPs (Studer et al., 2010). Using 
copper as a representative example, Studer and collaborators compared the cytotoxicity of 
copper metal NPs stabilized by a carbon layer to copper oxide NPs using Chinese hamster 
oocytes and HeLa cells. Measuring the intra- and extracellular solubility of the two materials 
in standard buffers (pH 7.4 cell culture medium and pH 5.5 lysosomal solution), the authors 
explained the differences in cytotoxicity on the basis of altered copper release: the particles at 
acidic pH of 5.5  dissolve more rapidly than at pH 7.4 (Studer et al., 2010). In fact, the well-
known mechanism of dissolution (Trojan horse-type mechanism) illustrates how NPs can 
bypass the protection of mammalian cells against heavy metal ions and explains the influence 
of physicochemical parameters on the cytotoxicity of a given metal (Xia et al., 2008).  
Other physicochemical characteristics as surface charge and surface area can also influence 
the NPs toxicity. Surface area is the physicochemical parameter usually proposed to represent 
at best the specific toxicity of nanoparticles, with a good correlation between the particle 
surface area and the inflammatory response of animals or cells exposed to the nanoparticles 
(Elder et al., 2006; Stoeger et al., 2005; MacNee and Donaldson, 2003). However, several 
studies failed to demonstrate such relationship: Warheit and collaborators did not found any 
difference among differently sized TiO2 NPs in inducing inflammation and cytotoxicity after 
intratracheal instillation in rats (Warheit et al., 2006). In the same year, no correlation 
between surface area and toxicity were found in murine alveolar macrophage cell line and 
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human macrophage cell line after exposure to an array of commercially manufactured 
inorganic nanoparticulate materials (Soto et al., 2006;). Recently, Lanone and colleagues 
failed to show any correlation between the cytotoxicity induced by a set of nanoparticle 
(included CuO, Ag, TiO2 and many others) and its equivalent spherical diameter or specific 
surface area in human alveolar epithelial (A549) and monocyte/macrophage (THP-1) cell 
lines (Lanone et al., 2009). 
The results observed in my work also did not show a clear correlation between surface area 
and toxicity: the CuO spheres (which have the largest surface area, 60 m
2
/g) showed a greater 
toxicity in most of the endpoints analysed, but they did not showed a marked difference 
respect to CuO rods (surface area 51 m
2
/g). Moreover, some endpoints showed CuO rods to 
be the most effective. Surface charge can also play a role in the toxic ability of CuO NPs: Z-
potential data showed that all CuO NPs here tested have positive surface charge, with a rank 
CuO rods > CuO INT > CuO spheres > CuO spindles. The data obtained in my work did not 
fit with this rank, suggesting that the toxic effects depend on several parameters. Compared 
with nanoparticles with a neutral or negative surface charge, positively charged nanoparticles 
are taken up at a faster rate (Thorek and Tsourkas, 2008; Slowing et al., 2006). It has been 
suggested that the cell membrane possesses a slight negative charge and cell uptake is driven 
by electrostatic attractions (Wang et al., 2010; Jin et al., 2009). CuO NPs were clearly 
observed in both the cell nucleus and the mitochondria after being internalized by human 
pulmonary epithelial A549 cells mainly through endocytosis, although part of the internalized 
CuO NPs were dynamically excreted to the extracellular environment (Wang et al., 2012). In 
addition, both rod-shaped and spherical CuO NPs were observed localized intracellularly in 
HepG2 cells after 2 h and 24 h of incubation (Piret et al., 2012).   
All the data available in literature show that CuO NPs cause toxicity independently from their 
size and their shape, suggesting that the physicochemical parameters of NPs act jointly in 
causing toxicity.  Moreover, although the primary role of oxidative stress mechanisms and the 
contribution of aneugenic responses in cytotoxicity and genotoxicity induced by CuO NPs is 
clear, it would need to be combined with a better understanding of the cellular uptake, in 
particular in the function of different cell types. 
 
Gold nanoparticles 
MTT assay revealed a significant dose-dependent decrease of cell viability in Raw 264.7 cells 
and PBL exposed to Au NPs, with Au5 the most effective at the lowest doses and Au15 at the 
highest doses. 
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Many in vitro toxicity tests were reported in the literature for gold NPs providing 
controversial results. Most studies have excluded the toxicity of gold NPs (4 nm–18 nm in 
diameter) studying cell viability, pro-apoptotic effects, oxidative stress and inflammatory 
response (Khan et al., 2007; Connor et al., 2005; Shukla et al., 2005). In contrast, cytotoxic 
and pro-apoptotic effects of gold particles ≤ 2 nm were reported (Pan et al., 2007; Tsoli et al., 
2005), as well as the impact of the charge of surface coatings on 2 nm particles on the 
reduction of Cos-1 cells viability (Goodman et al., 2004). Furthermore, exposure of 
fibroblasts to 13 nm gold particles caused morphological changes in the cytoskeleton and a 
reduction in cell proliferation (Pernodet et al., 2006). A pro-inflammatory response was 
observed after exposure to bovine serum albumin coated 25 nm gold particles in an epithelial 
airway model (Rothen-Rutishauser et al., 2007). The ability of Au5 to induce cytotoxicity at 
low doses, but not at high doses, could be explained by the possible aggregation of the NPs at 
high concentrations, and this could interfere with the entrance of Au5 inside the cells. 
However, it has been shown that in Balb/3T3 Au5 NPs were toxic only at high doses tested 
(from 50 to 300 µM) and after long-time exposure (72h); moreover no toxicity was observed 
after Au15 exposure, resulting in contrast with my findings (Coradeghini et al., 2013). The 
reasons for the controversial results obtained by Coradeghini and those obtained in my work 
might include different experimental set ups and particle characteristics (size, shape, surface 
charge). 
The proliferation index scored by CBMN cytome assay confirmed the results obtained by 
MTT assay. The reduction of mitotic figures was evident for all Au NPs exposures in both 
Raw 264.7 and PBL cells: the ability of Au NPs in inhibiting cell proliferation has been 
already suggested by Li and co-authors. They found that Au NPs (20 nm) influence in MRC-5 
human lung fibroblasts cell cycle pathways, inducing a reduction in the expression of critical 
checkpoint proteins that significantly inhibit cellular proliferation, besides causing oxidative 
stress and affecting genes associated with genomic stability and DNA repair (Li et al., 2008). 
All Au NPs tested in my work induced necrosis in PBL and in Raw 264.7, with a less 
significant tendency after Au40 exposure, while the apoptotic pathway seemed to be strongly 
activated only in PBL.  
The genotoxicity of Au NPs was determined by the CBMN cytome assay and the comet 
assay. The Au15 showed a greater genotoxicity both in human PBL and Raw 264.7, inducing 
significant increase in MN, NPB and NBUD. The comet assay revealed significant DNA 
damage at 2 and 24h of treatment both in PBL and in Raw 264.7: 2h treatment showed murine 
macrophages more sensitive to Au15 and PBL more damaged after Au5 exposure; after 24h 
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treatment, PBL showed a most pronounced DNA damage level than macrophages cell system, 
probably due to the clearance capacity of the Raw 264.7 cells. The modified version of the 
comet assay to detect DNA oxidative damage showed statistically significant damage at both 
2 and 24 hours, with Raw 264.7 a slightly more sensitive than lymphocytes. In PBL, short-
time exposure (2h) indicated Au5 as the most effective while Au15 seemed to induce the 
greater DNA damage after 24h treatment. In Raw 264.7, compared to Au5 and Au40, Au15 
caused a more severe oxidative DNA damage, both after 2 and 24h exposure. 
The well-known ability of Au NPs in inducing oxidative stress by increasing ROS production 
(Paino et al., 2012; De Jong et al., 2008) could explain the results obtained with the comet 
assay. Obviously other parameters, such as the dimension, could influence the Au NPs 
toxicity: unfortunately the evidences in literature are often in disagreement on the contribution 
given by the size. Gao and co-authors showed that in human liver cell line HL7702 8 nm Au 
NPs were highly toxic while larger 37 nm Au NPs were comparatively moderately toxic. 
GSH depletion induced by 8 nm Au NPs appears to be a key regulator of apoptotic potential 
in HL7702 cells, and the loss of mitochondrial GSH was sequentially associated with a 
decline in cytosolic GSH, along with mitochondrial H2O2 production and translocation of Bcl-
2–associated X protein (apoptosis promoter). Cytochrome c was then released, activating 
caspase-3 and irreversibly inducing apoptosis (Gao et al., 2011). Pan and collaborators 
examined in detail the size dependence of toxicity on four cell lines (human skin fibroblast, 
human skin melanoma, mouse fibroblast and mouse macrophage cell lines) by using gold 
atomic clusters of 0.8 nm (8 gold atoms), 1.2 nm (35), 1.4 nm (55), 1.8 nm (150) and 15-nm 
nanoparticles stabilized with triphenylphosphine derivatives. According to the MTT assay 
data, the clusters of 1.4 nm induced the most cytotoxic effect, and the 15nm Au NPs were not 
cytotoxic even at concentrations 100-fold higher than the IC50 for the small clusters. These 
data are in disagreement with those presented in my work, which showed Au15 inducing 
cytotoxic responses and damages at the DNA double strand. In addition, it has been 
demonstrated that the action of the 1.4-nm clusters led to cell necrosis after 12 h of incubation 
and that the use of the 1.2-nm clusters led to apoptosis (Pan et al., 2007). 
The toxicity of 1.4-nm Au55 clusters to healthy and tumorous human cells has also been 
reported previously by Tsoli and co-workers: they found than the 1.4nm Au55 clusters were 
more toxic than 18 nm gold nanoparticles and explained this results in the special relationship 
between Au55 and DNA, which is based on the perfect combination of cluster size and major 
groove dimension (Tsoli et al., 2005). In the work of Semmler-Behnke it was reported a high 
toxicity of the 1.4-nm cluster, administered by intratracheal instillation in rats after 24h and 
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that could have been due to the size similarity to B-form DNA (Semmler-Behnke et al., 
2008). In a recent study, it was shown that in human dermal fibroblasts 45-nm Au NPs were 
more markedly cytotoxic than 13-nm AuNPs, and the authors hypothesized that this effect 
might have been due to the greater damaging effect of the 45-nm Au NPs on vacuoles and, 
correspondingly, to the greater release of these gold NPs into the cytoplasm, with the normal 
cell function being disrupted (Mironava et al., 2010). The influence of chemical composition 
and dimension is still a matter of debate in literature. No toxicity of 10- to 50-nm citrate-
coated gold NPs to embryonal fibroblasts was found by the MTT assay up to the maximum 
particle concentration of 300 µM; however, such high concentrations induced changes in cell 
morphology (Qu and Lu, 2009), as also found by Coradeghini and co-authors (Coradeghini et 
al., 2013). In contrast to the cytotoxicity of quantum dots, no toxicity of 5-nm fluorescent Au 
NPs to fibroblasts was reported by Male and co-authors (Male et al., 2008). Similar data have 
been recorded by Jan and collaborators whom noted that even if Au NPs seemed not to be 
cytotoxic they could inhibit the proliferation and intracellular calcium release of HepG2 cells 
(Jan et al., 2008), while Schulz and co-authors did not find any significant increase in 
genotoxic damage after Au NP with different sizes (2, 20 and 200 nm) in male Wistar rats 
(Schulz et al., 2012). It is evident therefore that the size is not the only physicochemical 
characteristic we have to take into account when analysing NPs potential toxicity.  
Fluorescence in situ hybridization (FISH) using human pancentromeric probes was performed 
on PBL and Raw 264.7 cells and applied to distinguish between clastogenic and 
aneuploidogenic effects induced by Au NPs.  Both cell lines showed a clear increase of 
centromere-positive micronuclei, which was statistically significant compared to the untreated 
cells, highlighting a clear aneuploidogenic effect of Au NPs exposure. Particularly, Au15 was 
the most effective in inducing centromere-positive micronuclei in PBL and Raw 264.7 cells. 
PBL resulted more sensitive at lowest doses, while Raw 264.7 showed a major degree of 
missegregation at the highest doses. It is well-known that some NPs, such multi-walled 
carbon nanotubes and CoCr (Gonzalez et al., 2010), are able to induce aneuploidogenic 
damage, nevertheless this is the first evidence in literature about the ability of gold 
nanoparticles in inducing chromosome missegregation. We can hypothesize that Au NPs 
induce aneuploidy by mechanical interference with the cytoskeleton, as it has been observed 
that NPs are able to sequester a protein pattern including tubulin-beta chain, tubulin beta-2C 
chain and 26S protease regulatory subunit 6B tubulin alpha-1 proteins (Lundqvist et al., 
2011).  Moreover, the minor aneuploidogenic potential of Au5 could be caused by the NP 
dimension itself: as suggested by Lundqvist and co-workers, the small size of the 
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nanoparticles, which is in the range of the size of proteins, suggests a significant fluctuation in 
the protein corona composition, with a possible release of the proteins cited above (Lunqvist 
et al., 2011). 
In addition to size and aggregation, the surface charge must be considered when Au NPs 
potential toxicity is studied, since it has been proved that it can influence the NPs behaviour. 
The evaluation of three different Au NPs (positively charged, neutral, and negatively charged) 
showed that cell morphology was disrupted by all three NPs in a dose-dependent manner but 
affecting different cellular processes: positive and negative NPs inducing cell death through 
apoptosis and neutral NPs leading to necrosis in human keratinocyte cell line HaCaT 
(Schaeublin et al., 2011). Z-potential measurements of the Au nanoparticles used by 
Coradeghini and colleagues were found to be -26 mV ± 11 mV for Au 5 nm and −30 mV ± 12 
mV for Au 15 nm at pH = 6.5–7.5, and for both NPs sizes of −10 mV ± 10 mV after NPs 
dissolution in the Minimal Essential Medium supplemented with 10% foetal bovine serum 
and 0.5% penicillin/streptomicin. Since there was no difference in surface charge after the 
medium contact, the different behaviour of Au NPs observed should be ascribed to other 
physicochemical parameters such as size (Coradeghini et al., 2013). 
The solvent could also play an important role in the Au NPs toxicity, but in my work the Au 
NPs solvent used showed no toxic effects both in Raw 264.7 and in PBL. In accordance, 
Coradeghini and co-authors found no difference between the viability of Balb/3T3 negative 
controls (untreated samples) and the solvent controls (Coradeghini et al., 2013).  
In order to detect the possible toxic effect of NPs, a proper characterization is of importance 
because all the physicochemical parameters must be taken into account while analysing the 
findings. This is needed because, since Au NPs are used in many industrial and biomedical 
applications, a deeper knowledge of their action mechanisms and toxicity is important to 
avoid side effects due to the exposure, and to perform corrective actions which can make 
nanoparticles suitable for the commercialization.  
 
Silver nanoparticles 
The results obtained by the MTT viability test showed that the nanoparticles of small size, 
with a surface coating (Ag10-PVP) or without (Ag20), in the short-time exposure were more 
cytotoxic than the other tested Ag NPs. At 24 hour exposure, all the differently sized Ag 
nanoparticles significantly altered cell viability, especially those surface-coated with PVP. 
The results obtained by Trypan blue assay were, in contrast, showing a rank of toxicity 
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directly proportional to the size. In addition, Ag10-PVP induced a slight decrease in the viable 
cell number only at the highest doses after 24h treatment. 
Ag is a well-known antibacterial and antimicrobial compound and has been extensively used 
for both hygienic and healing purposes (You et al., 2012; Li et al., 2008; Dibrov et al., 2002): 
recently, nano-Ag has arisen new interest because of its unusual properties, especially in 
biomedicine: however, when using Ag NPs for therapeutic and diagnostic purposes, their in 
vivo fate and toxicity are crucial aspects that need to be evaluated (Li and Chen, 2011). 68.9 
nm AgNPs showed cytotoxicity in Raw 264.7 cells by increasing sub G1 fraction, which 
indicates cellular apoptosis, and they decreased intracellular glutathione level, increased NO 
secretion and increased gene expression of matrix metalloproteinases (Park et al., 2009). 
Asharani and co-workers reported that silver NPs induced G2/M phase arrest and DNA 
damage in human glioblastoma cells and human fibroblasts (AshaRani et al., 2009b): Ag NPs 
(7.5±2.5 nm particle size) induced G2/M phase arrest also in human renal proximal tubular 
epithelial cells (Kang et al., 2012). These findings lead to conclude that Ag NPs can suppress 
the progression of cell cycle independently from size. Data obtained in my work showed a 
severe reduction of mitotic figure, independently from the Ag NPs tested. 
All Ag NPs here tested also induced a significant increase in MN frequency in Raw 264.7 at 
the highest doses, with Ag40 the most effective. Moreover, there was a highly significant 
increase in nucleoplasmic bridges after not-coated Ag NPs exposures, while nuclear buds are 
significantly generated only after Ag20 exposure. 
The genotoxic effect, studied by the comet assay on the murine macrophages Raw 264.7 cell 
line, showed the ability of all four Ag NPs tested in damaging the DNA at different 
concentrations and at different time points (2h and 24h). In this contest, interestingly, the not-
coated intermediate size (Ag20) was the most harmful, while coated-NPs proved to be less 
harmful compared to the other Ag NPs. 
The U.S. Food and Drug Administration (FDA) has approved PVP for many uses and it is 
generally considered safe, but recently Kim and co-workers exposed zebrafish embryos to Ag 
NPs of 20 or 110 nm core size and found PVP coating more toxic than the citrate coating 
(Kim et al., 2013). Moreover, the DNA damage activity of the PVP (molecular weight 
40,000) has been documented by Song and collaborators: they found that PVP directly 
induced strand breakages of various DNA molecules (plasmid DNA pBR322 and 
fluorescently labeled ssDNA), implicating a cleavage activity. Moreover, reactive oxygen 
species (ROS) scavenging analysis showed that DNA cleavage activity of PVP is not related 
to ROS-induced oxidation and the major cleavage products of DNA were identified as two 
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purine bases, guanine and adenine, suggesting that PVPs have a novel depurination activity 
(Song et al., 2013). The results obtained in my work with the comet modified by the use of 
restriction enzymes ENDO III and FPG for the detection of oxidative damage confirmed the 
genotoxic potential of Ag NPs, especially in the purine detection by FPG: Ag40 resulted as 
the most effective, but also Ag10-PVP showed the ability in inducing oxidative DNA 
damage, even if with minor effect. This could be due to the ability of Ag NPs in entering 
inside the nucleus and the mitochondria as suggested by AshaRani and collaborators: they 
found that Ag NPs can be internalized into human lung fibroblast cells (IMR-90) and human 
glioblastoma cells (U251), and Ag NPs can induce the interruption of the mitochondrial 
respiratory chain with a consequent increase in the ROS production and disruption of the 
synthesis of ATP, eventually leading to DNA damage (AshaRani et al., 2009b). 
Size, shape and chemical composition have been deemed important properties when 
investigating NP-mediated toxicity (Auffan et al., 2008).  Since a fully characterization of the 
Ag NPs here used is not available yet, the impact of the physicochemical properties results 
difficult.  Nevertheless, with the exception of Ag10-PVP, the surface area of the Ag NPs 
tested can be extrapolated considering their nominal dimension and we found a rank of 
toxicity inversely proportional to the size only in the results obtained by Trypan blue assay. 
All the other endpoints investigated did not show any significant correlation with the surface 
area, leading to the conclusion that this physicochemical parameter did not play a significant 
role in the toxicity induction. In contrast, Carlson and co-workers, after exposing murine 
macrophages to differently sized Ag NPs (15, 30 and 55 nm Ag NPs), observed that the cell 
viability significantly decreased with increasing dose (10−75 μg/ml) of Ag-15nm NPs 
followed by Ag-30nm NPs, while no effects were found after Ag-55nm NPs exposure, 
suggesting a rank of toxicity inversely proportional to the size (Carlson et al., 2008). Böhmert 
and colleagues evaluated the effects of Ag NPs 20 nm and 40 nm coated with the peptides L-
cysteine, L-lysine and L- lysine on the human intestinal Caco-2 cells: they observed toxic 
effects dependent on size with 20 nm NPs more toxic than 40 nm (Böhmert et al., 2012).  
Since the toxicity of Ag is well-known, nano-silver preparations are largely used as efficient 
antibacterial, but in case they are used in biomedical applications (such as drug delivery and 
imaging/targeting) the reduction of their toxicity by an efficient capping is one of the main 
goal to achieve. As already discuss, PVP is FDA approved but in my work this capping did 
not lead to any reduction of toxicity. A possible explanation could be the stability of the 
capping, but Tejamaya and colleagues proved that PVP is stable up to 21 days, without 
showing a change of form of Ag NPs (Tejamaya et al., 2012). Conversely, NPs coated with 
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PEG showed changes in shape, in the state of aggregation and in the size of the core 
(Tejamaya et al., 2012). PVP-coated Ag NPs with 70 nm diameter were found to induce 
cytotoxic and genotoxic effect in A549 human lung carcinoma epithelial-like cell line 
(Foldbjerg et al., 2011). Importantly, N-acetyl-cysteine treatment of the cells significantly 
reduced the toxicity of Ag NPs up to 75%, suggesting the involvement of ROS (Foldbjerg et 
al., 2011). The toxic effects of Ag NPs could theoretically be related to the release of free 
silver ions, however two recent studies tested the content of free silver ions in Ag NP 
solutions and found low levels of Ag+ (0–1%) (Kim et al., 2009; Navarro et al., 2008). 
Furthermore, both studies concluded that the toxicity of Ag NP exposure could not be 
explained solely by the presence of Ag+ in the NP solution (Kim et al., 2009; Navarro et al., 
2008).  
Based on our results and according to the literature, the presence of Ag NPs increases cell 
death and DNA fragmentation. The question remains whether Ag NPs are intrinsically toxic 
or whether they act in a Trojan-horse like mode that enables uptake of the NPs and 
subsequent release of ions inside the cell, as suggested in previous reports (Park et al., 2010; 
Limbach et al., 2007). 
 
Silica nanoparticles 
The results obtained by the MTT viability test showed that the nanoparticles with functional 
amino group caused a cell viability decrease only at the highest doses, while the other two 
tested NPs did not show a positive response. Contrarily, the Trypan blue dye exclusion assay 
indicated a high toxicity only after 24h for the not-functionalized SiO2 NPs, while SiO2-
50AM did not show any effect in cell viability. As discussed before, Trypan blue assay could 
be not suitable for cytotoxic studies which involve NPs exposure. The more severe effect on 
viability of SiO2-50AM can be explained by the presence of the amino group on the NP 
surface: the electron pair of nitrogen can interfere with the cell membrane charge, leading to a 
damage of the phospholipid layer. Yang and co-workers also found a decrease in cell viability 
following 15 nm and 30 nm SiO2 NPs treatment in HaCaT cells: after 24h cell death was 
observed from 10 to 80 µg/ml in a dose-dependent way while there was no effect at 2.5 and 5 
µg/ml treatments (Yang et al., 2010). Contrarily, Uboldi and colleagues did not find any 
cytotoxic effect on Balb/3T3 cells after 72h treatment with SiO2 NPs whose diameter ranged 
between 15 nm and 300 nm, even at 100 µg/ml dose (Uboldi et al., 2012).  
Cytotoxicity data, obtained by scoring the apoptotic, necrotic and mitotic figures as well as 
the proliferation in CBMN cytome assay, showed a decrease in cell viability together with a 
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reduction of mitotic figures and an increase of apoptotic figures. These findings suggest that 
SiO2 NPs act through programmed cell death, as already hypotized by several authors (Lu et 
al., 2011; Eom and Choi, 2011; Yang et al., 2010 ). On the other hand, Bauer and co-authors 
showed that, in primary human umbilical vein endothelial cells, SiO2 NPs (unlabeled and 
labeled with a monofunctional perylene derivate (MPD), diameters between 16 nm and 310 
nm) attenuated both cell migration and proliferation upon cellular uptake and perinuclear 
accumulation. Based on these results, the authors proposed that the hypothetical action 
pathway could play through cellular uptake of NPs, which led to membrane damage, necrotic 
cell death and the subsequent release of intracellular contents (Bauer et al., 2011). Another 
report showed silica nanoparticles with sizes of 21 and 48 nm to be toxic in myocardial 
H9c2(2-1) cells and that the responses were mediated by particle-induced G1 phase arrest, 
triggering toxic response by generating oxidative stress (Ye et al., 2010).  
All SiO2 NPs I have investigated induced a significant increase in MN frequency in Raw 
264.7, and SiO2-50AM was the most effective. Moreover, there was a highly significant 
increase in nuclear buds frequency after exposure to silica NPs while NPBs were significantly 
generated especially at the intermediate doses. In contrast, Uboldi and colleagues investigated 
the potential cyto- and genotoxicity of different SiO2 NPs and did not find any cytotoxic or 
genotoxic effect in Balb/3T3 even after 72h 100 µg/ml exposure (Uboldi et al., 2012). This 
different behaviour can be explained as a cell type-dependent, and not concentration-
dependent, genotoxicity as already reported by Cha and Myung, who found that some cell 
lines responded more quickly than other to SiO2 NPs (Cha and Myung, 2007). 
The comet assay performed on murine macrophages showed the ability of SiO2 NPs in 
inducing DNA damage after 2 and 24h exposure, and SiO2-50AM resulted the most genotoxic 
after 24h treatment. Comet assay modified for the detection of oxidative damage was 
performed only after exposure to SiO2-50 and SiO2-50AM, and the results indicated that, after 
a 2h treatment, SiO2-50AM induced the highest genotoxic damage, as shown by the 
pyrimidine oxidation detected by ENDO III. SiO2-50, in contrast, caused oxidative damage in 
the purine bases after 24h exposure, showing thus its ability in inducing DNA damage by 
oxidative stress pathway. Taken together these results show that SiO2 NPs may induce 
genotoxicity via DNA strand breaks, oxidative DNA damage and mutation as already 
suggested by Nabeshi and co-workers, who observed endocytosis-dependent ROS generation 
and DNA damage in human keratinocytes cells after exposure to silica particles of 70, 300 
and 1000 nm in diameter (Nabeshi et al., 2011). The studies available in literature differ on 
the SiO2 ability in inducing genotoxic damage. For example, Stayton and collaborators found 
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that 50 nm luminescent silica particles have not exerted any genotoxicity in A549 cells 
(Stayton et al., 2009). In fact, comet assay, western blot analysis of the DNA and DNA 
agarose gel have not shown any significant DNA damage or any increased DNA repair 
activity in A549 following exposure to SiO2NPs, leading the authors to suggest that SiO2 NPs 
were not able to induce genotoxicity because NPs have not penetrated in the nuclei (Jin et al., 
2007). The presence of the fluorescent dye Ru(bipy)3 can play a role in the genotoxic effects 
induced by SiO2 NPs tested in my work. It is known that 40–70 nm fluorescent silica NPs 
exerted toxic effects inhibiting the replication and the cellular proliferation of HEp-2 human 
cells (Chen and von Mikecz, 2005). Furthermore, Al-Rawi and co-authors observed that in 
HeLa cells 70 nm fluorescent SiO2 NPs were not toxic in presence of serum but highly toxic 
in absence of the latter. A possible explanation is that serum protein can cover the NPs, 
reducing their toxicity (Al-Rawi et al., 2011). On the other hand, 50 nm Ru(bipy)3-labelled 
silica nanoparticles did not induce cytotoxic effects in A549 human pneumocytes (Jin et al., 
2007) and also 80 nm Ru(bipy)3-labelled SiO2 NPs did not exerted cytotoxicity in Balb/3T3 
mouse fibroblasts, even after 72h exposure (Uboldi et al., 2011).  
Among the SiO2 NPs studied in this work, SiO2-50AM induced the most severe genotoxic 
damage. Since the only difference between SiO2-50 and SiO2-50AM is the presence or 
absence of the NH2 group, it becomes evident that the amino group plays an important role in 
inducing cyto- and genotoxicity. There is a lack of knowledge concerning this aspect which 
cannot lead to a direct comparison, but it is known that nitrosative stress can lead to 
modification in proteins that contain transition metal centres and affect protein structure and 
function: all these reactions have the potential to cause changes in the catalytic activity of 
enzymes, altered cytoskeletal organization, and impaired cell signal transduction (Pacher et 
al., 2007). 
Considering the not-aminated SiO2 NPs tested in this work, a slightly size-dependent 
difference in the induction of cyto- and genotoxicity has been observed. In fact, SiO2-25 
showed a more pronounced decrease of cell viability and increase in chromosome damage and 
DNA fragmentation compared to SiO2-50. Also Ye and collaborators reported that 21 nm 
silica nanoparticles at concentrations above 300 μg/mL induced oxidative stress, apoptosis, 
and cytotoxicity in L-02 cells, but 48 nm and 86 nm silica nanoparticles, even at the 
concentration of 600 μg/mL, did not exhibit cytotoxicity (Ye et al., 2010). In contrast, data 
obtained from in vitro MTT assay show that silica nanoparticles 7–50 nm in size induce sharp 
growth inhibition of HepG2 cells above 80 μg/mL and that the strength of the antiproliferative 
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effect is in the order of SiO2 NPs 20 > SiO2 NPs 7 > SiO2 NP50, suggesting no size-
dependent effects (Lu et al., 2011).  
Nevertheless from the results presented in my study, the size of NPs is not the only 
physicochemical parameter to consider when nanotoxicological studies are performed. 
In conclusion, due to the potential use of SiO2 NPs in industrial application and in 
biomedicine, further studies to investigate any potential cytotoxic activities or DNA damages 
induced by SiO2 NPs are needed. 
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CONCLUSIONS 
 
It has been becoming increasingly evident that the physicochemical properties of 
nanomaterials play a central role in governing their cellular uptake and subsequent 
physiologic consequences. Furthermore, experimental conditions, such as cell type, dose and 
incubation time, are critical for nanotoxicological studies. 
Important is the fact that nanoparticles dispersed in a biological fluid bind to proteins which 
surround and attach to the NPs forming a ‘‘protein corona’’ that is associated with the 
nanoparticle and continuously exchanging with the proteins in the environment. Lundqvist 
and colleagues demonstrated that proteins associated to nanoparticles are likely to be 
implicated in transport mechanisms and in the uptake, and their abundance reflects the 
biological impact. They also observed that, irrespective of the nanoparticle composition, both 
surface properties and particle size influence the composition of the hard corona. For 
example, they often found immunoglobulins (IgGs) in the hard corona of NPs after exposure 
to human peripheral blood: this could lead to interference in the physiological mechanism of 
the immune system (Lundqvist et al., 2008).  
The molecular composition of the particles has also a strong influence on the exchange rates. 
It is interesting to note that, for example, for albumin the residence time is shorter on the more 
hydrophobic particles compared with the more hydrophilic (Cedervall et al., 2007a). 
Apolipoproteins, proteins involved in the transportation of lipids and cholesterol in the 
bloodstream and, as such, are expected to greatly affect the intracellular trafficking, fate and 
transport of nanoparticles in cells and animals, are often present in the hard corona (Lundqvist 
et al., 2008). APO-A1 and APO-B100, which are the major constituents of HDL and LDL, 
respectively, seem to be the most abundant: the shortage of these proteins could lead to a 
defect in lipid and cholesterol package and traffic (Lundqvist et al., 2008). Generally every 
protein carried by NPs to an organ or a tissue, which is not its physiological compartment in 
the organism, could cause the activation of pathways such as inflammation or apoptosis 
(Deng et al., 2010; Zhang et al., 2009a). Obviously these pathways interact with others 
involved in the NP toxicity, including mitochondria damage, activation of genes active in 
apoptotic and necrotic processes, DNA damage and interference with the mitotic spindle (De 
Stefano et al., 2012).  
Although the NPs can be used in various applications because of their unique properties and 
characteristics, still many efforts must be done to minimize their potential toxicity. One of 
these actions can be the addition, on the surface of the NPs, of functional groups (capping) 
 
 
110 
 
which might mitigated or eliminated the adverse effects of NPs. Coating is effective not just 
in stabilizing particles and avoiding agglomeration, but also in preventing the dissolution of 
NPs and the release of ions (Kirchner et al., 2005). Moreover, surface coatings can modify the 
surface charge or the surface composition, which can impact the intracellular distribution of 
NPs and the production of intracellular ROS that cause further toxicity. Polyethyleneglycol 
(PEG), polyvinylpyrrolidone (PVP) and citrate are some of the coatings now in use to avoid 
NPs toxicity but, since some reports (Song et al., 2013; Poynton et al., 2012) as well as the 
results obtained in my work, indicated a possible induction of cell damage caused by these 
coating, deeper studies are required. 
Making the NPs more secure from a toxicological point of view is certainly needed not only 
because they are present in a great number of daily-use products, but especially because of 
their increasing use in diagnostic and drug delivery (Spuch and Navarro, 2011; McDonough 
et al., 2011; Miqin et al., 2010; Ho et al., 2010).  Recently, due their ability to interact with 
the BBB cells, NPs have been tested as drug carrier in neurodegenerative diseases (ND), 
exploiting the existing physiological mechanisms of transport without interfering with the 
normal function of the barrier itself (Re et al., 2012). Receptor and adsorptive-mediated 
transcytosis are mechanisms to facilitate the transcellular transport of NPs from the blood to 
the brain. In order to achieve this task, NPs should carry a surface functionalization for 
targeting and crossing the BBB; moreover, to have a prolonged half-life in blood, the NPs 
must be able in avoiding the reticulo-endothelial system, where they could be metabolized or 
modified (Bhaskar et al., 2010). In addition, NPs should be non-toxic, biodegradable and 
biocompatible, non-inflammatory and non-immunogenic. Nowadays, strategies utilizing NP 
for the treatment of different ND such as Alzheimer disease (AD), Parkinson disease (PD), 
amyotrophic lateral sclerosis (ALS) and prion disease are under analysis. In AD, NPs seem to 
be able in interfering with Aβ aggregation or sequestering the peptide, not only centrally but 
even in the blood, with the idea of reducing its level in the brain (the so-called ‘sink effect’) 
(Mourtas et al., 2011; Bereczki et al., 2011; Canovi et al., 2011; Taylor et al., 2011; Gobbi et 
al., 2010). A different approach with nanoparticles is focused on the treatment of symptoms, 
by protecting neuronal cells against oxidative insults (Liu et al., 2009a; Liu et al., 2009b; 
Wilson et al., 2008). Nano-based approaches for the delivery and release of dopamine (DA) in 
the brain have been reported for the treatment of PD (Trapani et al., 2011; Modi et al., 2010); 
NPs have been used also as transfection vehicles for gene therapy in PD, as alternative to 
viruses, in order to limit the risk of excessive immune response as well as mutagenesis 
(Huang et al., 2010).  
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In vitro studies suggest the ability of different polyamine dendrimers to remove pathogenic 
prion isoform (PrPSc) from infected cells by dragging them to lysosomal degradation (Lim et 
al., 2010), whereas  only one report has been published concerning the preparation of solid 
lipid NP containing riluzole for the specific treatment of ALS (Bondì et al., 2010). While 
there is a growing interest on the application of NPs in biomedicine, little is known about 
their potential hazard for human health, in particular their possible toxic effects on CNS 
(Sousa et al., 2010; Ulbrich et al., 2009; Kim et al., 2007). Some NP, showing at the 
beginning promising features for their use in therapy and diagnosis, lately demonstrated their 
toxicity when utilized in vivo. This is the case of QD and nanotubes, which repeatedly proved 
to be toxic in vivo, and for this reason their future use in clinics will be likely limited to in 
vitro diagnostics (Win-Shwe and Fujimaki, 2011). In vivo experiments showed that also gold 
NP have some toxicity by causing transient microglia activation and induction of TLR-2 
promoter activity, in a shape- and surface-dependent manner, after intranasal administration to 
transgenic mice (Hutter et al., 2010).  
For these reasons the benefit-risk balance deriving from the entrance into the CNS, currently 
still unknown, should be carefully evaluated for engineered NPs intended for brain-specific 
drug delivery and diagnostics (Re et al., 2012). Further research on the toxicity of 
nanoparticles will fill this gap of knowledge, with a build-up of the physical and chemical 
properties of nanostructures influencing their in vivo and in vitro behaviour. Biological 
interactions linked to particle size, surface charge, composition and aggregation will be surely 
a focal point of future studies. 
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